<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.mdpi.com/journal/antibiotics');</script>

        <script> var body_html = '<body> <div > <div > <div > <a > <h2>25th Anniversary</h2> </a> <a > <h2>Journals</h2> </a> <div > <div > <h2>Information</h2> </div> <div > <div > <div > <a >For Authors</a> <a >For Reviewers</a> <a >For Editors</a> <a >For Librarians</a> <a >For Publishers</a> <a >For Societies</a> </div> <div > <a >Article Processing Charges</a> <a >Open Access Policy</a> <a >Institutional Open Access Program</a> <a >Editorial Process</a> <a >Awards</a> <a >Research and Publication Ethics</a> </div> </div> </div> </div> <a > <h2>Author Services</h2> </a> <div > <div > <h2>Initiatives</h2> </div> <div > <div > <div > <a >Sciforum</a> <a >MDPI Books</a> <a >Preprints</a> <a >Scilit</a> <a >SciProfiles</a> <a >Encyclopedia</a> <a >JAMS</a> <a >Proceedings Series</a> </div> </div> </div> </div> <a > <h2>About</h2> </a> </div> <div > <a >Sign In / Sign Up</a> </div> </div> </div> <div > <h2 >Notice</h2> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Notice</h2> <p> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div > <div > <a >Continue</a> <a >Cancel</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <p> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div > <p> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div > <p> Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div > <div >  </div> <section > <header> <div > <div > <div > <ul> <li > <a >25th Anniversary</a> </li> <li > <a >Journals</a> </li> <li > <a >Information</a> <ul > <li> <div > <div > <ul> <li> <a >For Authors</a> </li> <li> <a >For Reviewers</a> </li> <li> <a >For Editors</a> </li> <li> <a >For Librarians</a> </li> <li> <a >For Publishers</a> </li> <li> <a >For Societies</a> </li> </ul> </div> <div > <ul> <li> <a >Article Processing Charges</a> </li> <li> <a >Open Access Policy</a> </li> <li> <a >Institutional Open Access Program</a> </li> <li> <a >Editorial Process</a> </li> <li> <a >Awards</a> </li> <li> <a >Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >Author Services</a> </li> <li > <a >Initiatives</a> <ul > <li> <div > <div > <ul> <li> <a > Sciforum </a> </li> <li> <a > MDPI Books </a> </li> <li> <a > Preprints </a> </li> <li> <a > Scilit </a> </li> <li> <a > SciProfiles </a> </li> <li> <a > Encyclopedia </a> </li> <li> <a > JAMS </a> </li> <li> <a > Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >About</a> </li> </ul> </div> <div > <div> <a >Sign In / Sign Up</a> <a >Submit</a> </div> </div> </div> </div> <div > <div > <div > <div > <a > Covered in: PubMed </a> </div></div> <div > <div > <a > IMPACTFACTOR 4.639 </a> </div> </div> </div> <div > Journals </div> <div > Antibiotics </div> </div> </header> <div > <div > <div > <div > <div > <ul > <li> <a > <div > Non-Typhoidal Salmonella Infection in Children: Influence of Antibiotic Therapy on Postconvalescent Excretion and Clinical Course—A Systematic Review </div> </a> </li> <li > <a > <div > Implementation of a Cellulitis Management Plan in Three Australian Regional Health Services to Address an Evidence–Practice Gap in Antibiotic Prescribing </div> </a> </li> <li > <a > <div > FtsH Sensitizes Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics by Degrading YpfP, a Lipoteichoic Acid Synthesis Enzyme </div> </a> </li> <li > <a > <div > Probiotics and Gut Antimicrobial-Resistant Enterobacterales </div> </a> </li> <li > <a > <div > Earliest examples of Colistin Resistance Gene mcr-1 reported in Europe </div> </a> </li> </ul> </div> </div> <div > <div > <h2 >Journal Description</h2> </div> <div > <div > <h1> Antibiotics </h1> <div > Antibiotics is a <a >peer-reviewed</a>, open access journal on all aspects of antibiotics, published monthly online by MDPI. <ul> <li>Open Access— free for readers, with <a >article processing charges (APC)</a> paid by authors or their institutions.</li> <li>High Visibility: indexed within <a >Scopus</a>, <a >SCIE (Web of Science)</a>, <a >PubMed</a>, <a >PMC</a>, <a >Embase</a>, <a >CAPlus / SciFinder</a>, and many <a >other databases</a>.</li> <li>Journal Rank: JCR - Q2 (Infectious Diseases) / CiteScore - Q2 (General Pharmacology, Toxicology and Pharmaceutics)</li> <li>Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 13.3 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2021).</li> <li>Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> </ul> </div> <div > Impact Factor: 4.639 (2020) ; 5-Year Impact Factor: 4.849 (2020) </div> <div> <a > <i >subject</i> Imprint Information </a> <a > <i >get_app</i> Journal Flyer </a> <a > Open Access </a> ISSN: 2079-6382 </div> </div> </div> </div> <div > <div > <h2 >Latest Articles</h2> </div> <div > <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 253 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: <a >Abstract Page</a> <a >Full-Text HTML</a> </div> </div> <div >Open AccessArticle</div> <a >Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing <i>Klebsiella pneumoniae</i> in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination</a> <div > by <span ><div >Alla V. Filimonova</div>, </span><span ><div >Maria V. Golikova</div>, </span><span ><div >Elena N. Strukova</div>, </span><span ><div >Yury A. Portnoy</div>, </span><span ><div >Anastasiya A. Kuznetsova</div> and </span><span ><div >Stephen H. Zinner</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1520; https://doi.org/10.3390/antibiotics10121520 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Traditionally, the antibacterial activity of β-lactam antibiotics in the presence of β-lactamase inhibitors is determined at the fixed inhibitor concentration. This traditional approach does not consider the ratio of antibiotic-to-inhibitor concentrations achieved in humans. To explore whether an alternative pharmacokinetically based approach to [...] Read more. </div> <div > Traditionally, the antibacterial activity of β-lactam antibiotics in the presence of β-lactamase inhibitors is determined at the fixed inhibitor concentration. This traditional approach does not consider the ratio of antibiotic-to-inhibitor concentrations achieved in humans. To explore whether an alternative pharmacokinetically based approach to estimate MICs in combinations is predictive of antimicrobial efficacy, the effects of imipenem and doripenem alone and in combination with relebactam were studied in time-kill experiments against carbapenemase-producing <i>Klebsiella pneumoniae</i>. The carbapenem-to-relebactam concentration ratios in time-kill assays were equal to the therapeutic 24-h area under the concentration-time curve (AUC) ratios of the drugs (1.5/1). The simulated levels of carbapenem and relebactam were equal to their concentrations achieved in humans. When effects of combined regimens were plotted against respective C/MICs, a sigmoid relationship was obtained only with MICs determined by pharmacokinetically based method. The effectiveness of both carbapenems in the presence of relebactam was comparable by the results of time-kill experiments. These findings suggest that (1) antibiotic/inhibitor MICs determined at a pharmacokinetically based concentration ratio allow an adequate assessment of carbapenem susceptibility in carbapenemase-producing <i>K. pneumoniae</i> strains and can be used to predict antibacterial effects; (2) in time-kill experiments, the effects of imipenem and doripenem in the presence of relebactam are comparable. Full article </div> </div> <div > (This article belongs to the Special Issue Alternative Approaches to Treating Antimicrobial Resistant Infections) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Educational Activities for Students and Citizens Supporting the One-Health Approach on Antimicrobial Resistance <div > by <span ><div >Massimiliano Marvasi</div>, </span><span ><div >Lilliam Casillas</div>, </span><span ><div >Alberto Vassallo</div> and </span><span ><div >Diane Purchase</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1519; https://doi.org/10.3390/antibiotics10121519 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Antibiotic resistance is one of the biggest threats to global health, food security and development. Urgent action is needed at all levels of society to reduce the impact and spread of antibiotic resistance. For a more sustaining approach, education in children, college students, [...] Read more. </div> <div > Antibiotic resistance is one of the biggest threats to global health, food security and development. Urgent action is needed at all levels of society to reduce the impact and spread of antibiotic resistance. For a more sustaining approach, education in children, college students, citizens and caregivers are essential. The One-Heath approach is a collaborative, multisectoral and transdisciplinary strategy in which, no single organizations or sector can address the issue of antimicrobial resistance at the human–environment interface alone. Within this strategy, education plays a central role. In this scoping review, we highlighted a range of learning activities on antibiotic resistance as part of the One-Health approach. In particular, those applications that can be introduced to a wide audience to help arrest the current crisis for the next generation. The review identifies a high number of teaching opportunities: board and role-play games, round tables, musicals, e-learning and environmental experiments to couple with more curricula and formal education to inform a diverse group of audiences. Full article </div> </div> <div > (This article belongs to the Special Issue Antimicrobial Resistance and the Environment: One Health Approach) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 329 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Impact and Sustainability of Antibiotic Stewardship on Antibiotic Prescribing in Visceral Surgery <div > by <span ><div >Magdalena Monika Gruber</div>, </span><span ><div >Alexandra Weber</div>, </span><span ><div >Jette Jung</div>, </span><span ><div >Jens Werner</div> and </span><span ><div >Rika Draenert</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1518; https://doi.org/10.3390/antibiotics10121518 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Background: Antibiotic stewardship (AS) ward rounds are a core element in clinical care for surgical patients. Therefore, we aimed to analyze the impact of surgical AS ward rounds on antibiotic prescribing, and the sustainability of the effect after the AS interventions are no [...] Read more. </div> <div > Background: Antibiotic stewardship (AS) ward rounds are a core element in clinical care for surgical patients. Therefore, we aimed to analyze the impact of surgical AS ward rounds on antibiotic prescribing, and the sustainability of the effect after the AS interventions are no longer provided. Methods: On four wards of the department of visceral surgery, we conducted two independent retrospective prescribing analyses (P1, P2) over three months each. During the study periods, the level of AS intervention differed for two of the four wards (ward rounds/no ward rounds). Results: AS ward rounds were associated with a decrease in overall antibiotic consumption (91.1 days of therapy (DOT)/100 patient days (PD) (P1), 70.4 DOT/100PD (P2)), and improved de-escalation rates of antibiotic therapy (W1/2: 25.7% (P1), 40.0% (P2), <i>p</i> = 0.030; W3: 15.4 (P1), 24.2 (P2), <i>p</i> = 0.081). On the ward where AS measures were no longer provided, overall antibiotic usage remained stable (71.3 DOT/100PD (P1), 74.4 DOT/100PD (P2)), showing the sustainability of AS measures. However, the application of last-resort compounds increased from 6.4 DOT/100PD to 12.1 DOT/100PD (oxazolidinones) and from 10.8 DOT/100PD to 13.2 DOT/100PD (carbapenems). Conclusions: Antibiotic consumption can be reduced without negatively affecting patient outcomes. However, achieving lasting positive changes in antibiotic prescribing habits remains a challenge. Full article </div> </div> <div > (This article belongs to the Special Issue The Optimization of Antimicrobial Prescribing and Stewardship) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 918 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Essential Oil Blends: The Potential of Combined Use for Respiratory Tract Infections <div > by <span ><div >Stephanie Leigh-de Rapper</div>, </span><span ><div >Alvaro Viljoen</div> and </span><span ><div >Sandy van Vuuren</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1517; https://doi.org/10.3390/antibiotics10121517 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > This study investigated the potential efficacy of 369 commercial essential oil combinations for antimicrobial, anti-toxic and anti-inflammatory activity with the aim of identifying synergy among essential oils commonly used in combination by aromatherapists for respiratory purposes. Essential oil combinations were assessed for their [...] Read more. </div> <div > This study investigated the potential efficacy of 369 commercial essential oil combinations for antimicrobial, anti-toxic and anti-inflammatory activity with the aim of identifying synergy among essential oils commonly used in combination by aromatherapists for respiratory purposes. Essential oil combinations were assessed for their antimicrobial activities using a panel of Gram-positive, Gram-negative, and yeast strains associated with respiratory tract infections. The antimicrobial activity was measured by determining the minimal inhibitory concentration (MIC) of microbial growth. The fractional inhibitory concentration index (ΣFIC) was calculated to determine the antimicrobial interactions between the essential oils in the combination. The toxicity of the essential oil combinations was tested <i>in vitro</i> using the brine shrimp lethality assay, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay on RAW 264.7 mouse macrophage cells and A549 lung cancer cell lines. In addition, an inflammatory response was evaluated measuring nitric oxide production. The essential oils, when in combination, demonstrated an increased antimicrobial effect, a reduction in toxicity and provided improved anti-inflammatory outcomes. Five distinct combinations [<i>Cupressus</i> <i>sempervirens</i> (cypress) in combination with <i>Melaleuca</i> <i>alternifolia</i> (tea tree), <i>Hyssopus</i> <i>officinalis</i> (hyssop) in combination with <i>Rosmarinus</i> <i>officinalis</i> (rosemary), <i>Origanum</i> <i>marjorana</i> (marjoram) in combination with <i>M.</i> <i>alternifolia</i>, <i>Myrtus</i> <i>communis</i> (myrtle) in combination with <i>M.</i> <i>alternifolia</i> and <i>Origanum</i> <i>vulgare</i> (origanum) in combination with <i>M.</i> <i>alternifolia</i>] were found to be the most promising, demonstrating antimicrobial activity, reduced cytotoxicity and improved anti-inflammatory effects. With the increased prevalence of respiratory tract infections and the growing antimicrobial resistance development associated with antimicrobial treatments, this study provides a promising complementary alternative for the appropriate use of a selection of essential oil combinations for use in the respiratory tract. Full article </div> </div> <div > (This article belongs to the Special Issue 10th Anniversary of Antibiotics—Recent Advances in Plant-Derived Antibiotics) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 3176 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> <a >Anti-Colonization Effect of Au Surfaces with Self-Assembled Molecular Monolayers Functionalized with Antimicrobial Peptides on <i>S. epidermidis</i></a> <div > by <span ><div >Eskil André Karlsen</div>, </span><span ><div >Wenche Stensen</div>, </span><span ><div >Eric Juskewitz</div>, </span><span ><div >Johan Svenson</div>, </span><span ><div >Mattias Berglin</div> and </span><span ><div >John Sigurd Mjøen Svendsen</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1516; https://doi.org/10.3390/antibiotics10121516 - 10 Dec 2021 </div> <div > Abstract <div > Medical devices with an effective anti-colonization surface are important tools for combatting healthcare-associated infections. Here, we investigated the anti-colonization efficacy of antimicrobial peptides covalently attached to a gold model surface. The gold surface was modified by a self-assembled polyethylene glycol monolayer with an [...] Read more. </div> <div > Medical devices with an effective anti-colonization surface are important tools for combatting healthcare-associated infections. Here, we investigated the anti-colonization efficacy of antimicrobial peptides covalently attached to a gold model surface. The gold surface was modified by a self-assembled polyethylene glycol monolayer with an acetylene terminus. The peptides were covalently connected to the surface through a copper-catalyzed [3 + 2] azide-acetylene coupling (CuAAC). The anti-colonization efficacy of the surfaces varied as a function of the antimicrobial activity of the peptides, and very effective surfaces could be prepared with a 6 log unit reduction in bacterial colonization. Full article </div> </div> <div > (This article belongs to the Special Issue Antimicrobial Materials and Surface) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model <div > by <span ><div >Arundhati Maitra</div>, </span><span ><div >Priya Solanki</div>, </span><span ><div >Zahra Sadouki</div>, </span><span ><div >Timothy D. McHugh</div> and </span><span ><div >Frank Kloprogge</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1515; https://doi.org/10.3390/antibiotics10121515 - 10 Dec 2021 </div> <div > Abstract <div > Mycobacterial infections are difficult to treat, requiring a combination of drugs and lengthy treatment times, thereby presenting a substantial burden to both the patient and health services worldwide. The limited treatment options available are under threat due to the emergence of antibiotic resistance [...] Read more. </div> <div > Mycobacterial infections are difficult to treat, requiring a combination of drugs and lengthy treatment times, thereby presenting a substantial burden to both the patient and health services worldwide. The limited treatment options available are under threat due to the emergence of antibiotic resistance in the pathogen, hence necessitating the development of new treatment regimens. Drug development processes are lengthy, resource intensive, and high-risk, which have contributed to market failure as demonstrated by pharmaceutical companies limiting their antimicrobial drug discovery programmes. Pre-clinical protocols evaluating treatment regimens that can mimic in vivo PK/PD attributes can underpin the drug development process. The hollow fibre infection model (HFIM) allows for the pathogen to be exposed to a single or a combination of agents at concentrations achieved in vivo–in plasma or at infection sites. Samples taken from the HFIM, depending on the analyses performed, provide information on the rate of bacterial killing and the emergence of resistance. Thereby, the HFIM is an effective means to investigate the efficacy of a drug combination. Although applicable to a wide variety of infections, the complexity of anti-mycobacterial drug discovery makes the information available from the HFIM invaluable as explored in this review. Full article </div> </div> <div > (This article belongs to the Special Issue Tackling Antimicrobial Resistance in Global Infectious Bacterial Pathogens) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 74 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> <a >Chemical, Cytotoxic, and Anti-Inflammatory Assessment of Honey Bee Venom from <i>Apis mellifera intermissa</i></a> <div > by <span ><div >Iouraouine El Mehdi</div>, </span><span ><div >Soraia I. Falcão</div>, </span><span ><div >Mustapha Harandou</div>, </span><span ><div >Saïd Boujraf</div>, </span><span ><div >Ricardo C. Calhelha</div>, </span><span ><div >Isabel C. F. R. Ferreira</div>, </span><span ><div >Ofélia Anjos</div>, </span><span ><div >Maria G. Campos</div> and </span><span ><div >Miguel Vilas-Boas</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1514; https://doi.org/10.3390/antibiotics10121514 - 10 Dec 2021 </div> <div > Abstract <div > The venom from <i>Apis mellifera intermissa</i>, the main honey bee prevailing in Morocco, has been scarcely studied, despite its known potential for pharmacological applications. In the present work, we investigated the composition, the anti-inflammatory activity, and the venom’s cytotoxic properties from fifteen [...] Read more. </div> <div > The venom from <i>Apis mellifera intermissa</i>, the main honey bee prevailing in Morocco, has been scarcely studied, despite its known potential for pharmacological applications. In the present work, we investigated the composition, the anti-inflammatory activity, and the venom’s cytotoxic properties from fifteen honey bee venom (HBV) samples collected in three regions: northeast, central, and southern Morocco. The chemical assessment of honey bee venom was performed using LC-DAD/ESI/MS<sup>n</sup>, NIR spectroscopy and AAS spectroscopy. The antiproliferative effect was evaluated using human tumor cell lines, including breast adenocarcinoma, non-small cell lung carcinoma, cervical carcinoma, hepatocellular carcinoma, and malignant melanoma. Likewise, we assessed the anti-inflammatory activity using the murine macrophage cell line. The study provides information on the honey bee venom subspecies’ main components, such as melittin, apamin, and phospholipase A2, with compositional variation depending on the region of collection. Contents of toxic elements such as cadmium, chromium, and plumb were detected at a concentration below 5 ppm, which can be regarded as safe for pharmaceutical use. The data presented contribute to the first study in HBV from <i>Apis mellifera intermissa</i> and highlight the remarkable antiproliferative and anti-inflammatory effects of HBV, suggesting it to be a candidate natural medicine to explore. Full article </div> </div> <div > (This article belongs to the Special Issue Honey Bee Products as an Alternative or Complement to Classical Antibiotics – 2nd Edition) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Bacterial Epidemiology of Surgical Site Infections after Open Fractures of the Lower Limb: A Retrospective Cohort Study <div > by <span ><div >Tracie Joyner Youbong</div>, </span><span ><div >Astrid De Pontfarcy</div>, </span><span ><div >Maxence Rouyer</div>, </span><span ><div >Alessio Strazzula</div>, </span><span ><div >Catherine Chakvetadze</div>, </span><span ><div >Clara Flateau</div>, </span><span ><div >Samir Sayegh</div>, </span><span ><div >Coralie Noel</div>, </span><span ><div >Aurélia Pitsch</div>, </span><span ><div >Abdelmalek Abbadi</div> and </span><span ><div >Sylvain Diamantis</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1513; https://doi.org/10.3390/antibiotics10121513 - 10 Dec 2021 </div> <div > Abstract <div > Open lower limb fractures are common injuries, and the occurrence of infectious complications after open fractures is a usual problem. The rate of surgical site infections (SSIs) and the nature and resistance of the germs responsible for SSIs remain poorly described. Our aim [...] Read more. </div> <div > Open lower limb fractures are common injuries, and the occurrence of infectious complications after open fractures is a usual problem. The rate of surgical site infections (SSIs) and the nature and resistance of the germs responsible for SSIs remain poorly described. Our aim was to describe the bacterial epidemiology of SSIs after surgical management of an open lower limb fracture. We conducted a retrospective monocentric cohort study from 1 January 2012 to 31 December 2020 based on the analysis of inpatient records in a non-university hospital of Ile de France region. All patients who underwent surgery for an open lower limb fracture were included. A total of 149 patients were included. In our population, 19 (12.7%) patients developed an SSI. Of these 19 patients, the sample was polymicrobial in 9 (47.4%) patients. In 9 (45%) cases, the samples identified a group 3 enterobacteria, Enterobacter cloacae being the main one in 7 (36.9%) cases. Staphylococci were identified in 11 patients, with Staphylococcus aureus in 9 (47.4%). All Staphylococcus aureus were susceptible to methicillin, and all enterobacteria were susceptible to C3G. Among all SSI, 10 (58.8%) contained at least one germ resistant to amoxicillin/clavulanic acid (AMC). The SSIs rate was 12.7%. The main pathogens identified were Enterobacter cloacae and Staphylococcus aureus. The presence of early SSI caused by group 3 Enterobacteriaceae renders current antibiotic prophylaxis protocols inadequate with AMC in half the cases. Full article </div> </div> <div > (This article belongs to the Special Issue Antibiotic Prophylaxis for Surgical Site Infection in General Surgery) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from The Netherlands Pharmacovigilance Centre <div > by <span ><div >Jean Marie Vianney Habarugira</div>, </span><span ><div >Linda Härmark</div> and </span><span ><div >Albert Figueras</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1512; https://doi.org/10.3390/antibiotics10121512 - 09 Dec 2021 </div> <div > Abstract <div > (1) Background: Antimicrobial resistance (AMR) requires urgent multidisciplinary solutions, and pharmacovigilance has the potential to strengthen current antimicrobial stewardship strategies. This study aimed to characterize AMR-relevant adverse drug reaction (ADR) reports submitted to The Netherlands Pharmacovigilance Centre; (2) Methods: We carried out a [...] Read more. </div> <div > (1) Background: Antimicrobial resistance (AMR) requires urgent multidisciplinary solutions, and pharmacovigilance has the potential to strengthen current antimicrobial stewardship strategies. This study aimed to characterize AMR-relevant adverse drug reaction (ADR) reports submitted to The Netherlands Pharmacovigilance Centre; (2) Methods: We carried out a descriptive analysis of ADR reports submitted to Lareb, coded with AMR-relevant MedDRA Preferred Terms (PTs); (3) Results: Between 1998 and January 2019, 252 AMR-relevant ADR reports were submitted to Lareb. The most frequent antibiotics were tobramycin (<i>n</i> = 89; 35%), colistin (<i>n</i> = 30; 11.9%), cipro-floxacin (<i>n</i> = 16; 6.3%), doxycycline (<i>n</i> = 14; 5.5%), and aztreonam (<i>n</i> = 12; 4.8%). The PTs used included off label use (<i>n</i> = 91; 36.1%), drug ineffective (<i>n</i> = 71; 28.2%), product use in unapproved indication (<i>n</i> = 28; 11.1%), pathogen resistance (<i>n</i> = 14; 5.6%), and drug resistance (<i>n</i> = 13; 5.2%). 54% of the reports were on Watch antibiotics and 19% were involved in the Reserve group. In the Watch group, “off label use” and “product use in unapproved indication” were the most frequent PTs and the majority of reports on Reserve antibiotics were coded as “Off label”. A sharp increase in the number of reports was observed in the three consecutive years with 21 in 2013, 54 in 2014, and 83 in 2015; (4) Conclusions: In addition to existing AMR monitoring strategies, pharmacovigilance databases can serve as a source of data on suspected resistance and inappropriate use. Future research should explore how these AMR-relevant MedDRA Terms are used in resource-limited settings with less capacity to generate laboratory-confirmed resistance data. Full article </div> </div> <div > (This article belongs to the Special Issue 10th Anniversary of Antibiotics — Recent Advances in Rational Antimicrobial Use) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 119 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Real Life Clinical Impact of Antimicrobial Stewardship Actions on the Blood Culture Workflow from a Microbiology Laboratory <div > by <span ><div >Jose Maria López-Pintor</div>, </span><span ><div >Javier Sánchez-López</div>, </span><span ><div >Carolina Navarro-San Francisco</div>, </span><span ><div >Ana Maria Sánchez-Díaz</div>, </span><span ><div >Elena Loza</div> and </span><span ><div >Rafael Cantón</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1511; https://doi.org/10.3390/antibiotics10121511 - 09 Dec 2021 </div> <div > Abstract <div > Background: Accelerating the diagnosis of bacteremia is one of the biggest challenges in clinical microbiology departments. The fast establishment of a correct treatment is determinant on bacteremic patients’ outcomes. Our objective was to evaluate the impact of antimicrobial therapy and clinical outcomes of [...] Read more. </div> <div > Background: Accelerating the diagnosis of bacteremia is one of the biggest challenges in clinical microbiology departments. The fast establishment of a correct treatment is determinant on bacteremic patients’ outcomes. Our objective was to evaluate the impact of antimicrobial therapy and clinical outcomes of a rapid blood culture workflow protocol in positive blood cultures with Gram-negative bacilli (GNB). Methods: A quasi-experimental before–after study was performed with two groups: (i) control group (conventional work-protocol) and (ii) intervention group (rapid workflow-protocol: rapid identification by Matrix-Assisted Laser Desorption/Ionization-Time-Of-Flight (MALDI-TOF) and antimicrobial susceptibility testing (AST) from bacterial pellet without overnight incubation). Patients were divided into different categories according to the type of intervention over treatment. Outcomes were compared between both groups. Results: A total of 313 patients with GNB-bacteremia were included: 125 patients in the control group and 188 in the intervention. The time from positive blood culture to intervention on antibiotic treatment decreased from 2.0 days in the control group to 1.0 in the intervention group (<i>p</i> &lt; 0.001). On the maintenance of correct empirical treatment, the control group reported 2.0 median days until the clinical decision, while in the intervention group was 1.0 (<i>p</i> &lt; 0.001). In the case of treatment de-escalation, a significant difference between both groups (4.0 vs. 2.0, <i>p</i> &lt; 0.001) was found. A decreasing trend on the change from inappropriate treatments to appropriate ones was observed: 3.5 vs. 1.5; <i>p</i> = 0.12. No significant differences were found between both groups on 7-days mortality or on readmissions in the first 30-days. Conclusions: Routine implementation of a rapid workflow protocol anticipates the report of antimicrobial susceptibility testing results in patients with GNB-bacteremia, decreasing the time to effective and optimal antibiotic therapy. Full article </div> </div> <div > (This article belongs to the Special Issue Key Collaborations between Antimicrobial Stewardship Clinical Microbiology – Focus on Diagnostic Stewardship) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Comparison of Low-Versus High-Dose Steroids in the Clinical Outcome of Hospitalized COVID-19 Patients <div > by <span ><div >Zubia Jamil</div>, </span><span ><div >Fahad N. Almajhdi</div>, </span><span ><div >Samreen Khalid</div>, </span><span ><div >Muhammad Asghar</div>, </span><span ><div >Jamal Ahmed</div> and </span><span ><div >Yasir Waheed</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1510; https://doi.org/10.3390/antibiotics10121510 - 09 Dec 2021 </div> <div > Abstract <div > (1) Objectives: Patients with COVID-19 infection have been given various formulations and dosages of steroids over the last year and a half. This study aims to compare the effects of different formulations and doses of steroids on the 30 day in-hospital clinical outcome [...] Read more. </div> <div > (1) Objectives: Patients with COVID-19 infection have been given various formulations and dosages of steroids over the last year and a half. This study aims to compare the effects of different formulations and doses of steroids on the 30 day in-hospital clinical outcome of patients with severe COVID-19 infection. (2) Material and Methods: An analysis of a retrospective cohort was carried out on patients with severe COVID-19 infection in a high-dependency unit (HDU) between February and July 2021. In total, 557 patients were included in this study. Patients who did not receive steroids (124) were excluded. Patients were divided into three groups based on dosages of steroids (Dexamethasone = 6 mg/day, Dexamethasone &gt; 6 mg/day, and Methylprednisolone = 500 mg/day), given for 10 days. First, clinical outcome was evaluated on the 10th day of steroid administration in relation to mode of oxygen delivery. Then, Kaplan–Meier analysis was employed to determine 30 day in-hospital survival in relation to the use of steroid. (3) Results: Three groups were statistically equal according to biochemical characteristics. After 10 days of Methylprednisolone = 500 mg/day vs. Dexamethasone = 6 mg/day, 10.9% vs. 6.2% of patients required invasive ventilation (<i>p</i> = 0.01). The 30 day in-hospital mortality was lowest, 3%, in individuals receiving Dexamethasone = 6 mg/day, compared to 3.9% in individuals receiving Dexamethasone &gt; 6 mg/day and 9.9% in individuals receiving Methylprednisolone = 500 mg/day, respectively. The median elapsed time was longer than 28 days between admission and outcome for Dexamethasone = 6 mg/day, compared to 18 days for Dexamethasone &gt; 6 mg/day and 17 days for Methylprednisolone = 500 mg/day (<i>p</i> = &lt; 0.0001). Dexamethasone = 6 mg/day was found to be a positive predictor of clinical outcome in COVID-19 patients on regression analysis. (4) Conclusions: Low-dose Dexamethasone (6 mg/day) is more effective than high-dose Dexamethasone and Methylprednisolone in improving the survival outcome of severe COVID-19 cases. Full article </div> </div> <div > (This article belongs to the Special Issue Antibiotics and Therapeutic Agent Prescription in COVID-19 Management) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> The Effect of Pharmacist-Led Intervention on Surgical Antibacterial Prophylaxis (SAP) at an Orthopedic Unit <div > by <span ><div >Adina Fésüs</div>, </span><span ><div >Ria Benkő</div>, </span><span ><div >Mária Matuz</div>, </span><span ><div >Orsolya Kungler-Gorácz</div>, </span><span ><div >Márton Á. Fésüs</div>, </span><span ><div >Tamás Bazsó</div>, </span><span ><div >Zoltán Csernátony</div> and </span><span ><div >Gábor Kardos</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1509; https://doi.org/10.3390/antibiotics10121509 - 09 Dec 2021 </div> <div > Abstract <div > Perioperative antibiotic use is a common reason for antibiotic misuse. Evidence suggests that adherence to SAP guidelines may improve outcomes. The purpose of this study was to analyze the impact of pharmacist-led antibiotic stewardship interventions on SAP guideline compliance. The study was conducted [...] Read more. </div> <div > Perioperative antibiotic use is a common reason for antibiotic misuse. Evidence suggests that adherence to SAP guidelines may improve outcomes. The purpose of this study was to analyze the impact of pharmacist-led antibiotic stewardship interventions on SAP guideline compliance. The study was conducted at an Orthopedic Department of a tertiary care medical center. SAP compliance and antibiotic exposure in the pre-intervention and intervention period was compared using chi-square, Fisher exact, and Mann-Whitney tests, as appropriate. Prophylactic antibiotic use in orthopedic joint arthroplasties (overall guideline adherence: agent, dose, frequency, duration), clinical outcomes (length of stay-LOS, number of surgical site infections-SSIs), antibiotic exposure and direct antibiotic costs were compared between pre-intervention and intervention periods. Significant improvement in mean SAP duration (by 42.9%, 4.08 ± 2.08 vs. 2.08 ± 1.90 days, <i>p</i> ˂ 0.001), and overall guideline adherence regarding antibiotic use (by 56.2%, from 2% to 58.2%, <i>p</i> ˂ 0.001) were observed. A significant decrease was observed in antibiotic exposure in SAP (by 41%, from 6.07 ± 0.05 to 3.58 ± 4.33 DDD/patient, <i>p</i> ˂ 0.001), average prophylactic antibiotic cost (by 54.8%, 9278.79 ± 6094.29 vs. 3598.16 ± 3354.55 HUF/patient), and mean LOS (by 37.2%, from 11.22 ± 6.96 to 7.62 ± 3.02 days, <i>p</i> &lt; 0.001); and a slight decrease in the number of confirmed SSIs was found between the two periods (by 1.8%, from 3% to 1.2%, <i>p</i> = 0.21). Continuous presence of the clinical pharmacist led to significant improvement in SAP guideline adherence, which was accompanied by decreased antibiotic exposure and cost. Full article </div> </div> <div > (This article belongs to the Special Issue Antibiotic Use in European Hospitals and Pharmacies) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessSystematic Review</div> <a >Global Prevalence of Nosocomial Multidrug-Resistant <i>Klebsiella pneumoniae</i>: A Systematic Review and Meta-Analysis</a> <div > by <span ><div >Nur Ain Mohd Asri</div>, </span><span ><div >Suhana Ahmad</div>, </span><span ><div >Rohimah Mohamud</div>, </span><span ><div >Nurmardhiah Mohd Hanafi</div>, </span><span ><div >Nur Fatihah Mohd Zaidi</div>, </span><span ><div >Ahmad Adebayo Irekeola</div>, </span><span ><div >Rafidah Hanim Shueb</div>, </span><span ><div >Leow Chiuan Yee</div>, </span><span ><div >Norhayati Mohd Noor</div>, </span><span ><div >Fatin Hamimi Mustafa</div>, </span><span ><div >Chan Yean Yean</div> and </span><span ><div >Nik Yusnoraini Yusof</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1508; https://doi.org/10.3390/antibiotics10121508 - 08 Dec 2021 </div> <div > Abstract <div > The emergence of nosocomial multidrug-resistant <i>Klebsiella pneumoniae</i> is an escalating public health threat worldwide. The prevalence of nosocomial infections due to <i>K. pneumoniae</i> was recorded up to 10%. In this systematic review and meta-analysis, which were conducted according to the guidelines of Preferred [...] Read more. </div> <div > The emergence of nosocomial multidrug-resistant <i>Klebsiella pneumoniae</i> is an escalating public health threat worldwide. The prevalence of nosocomial infections due to <i>K. pneumoniae</i> was recorded up to 10%. In this systematic review and meta-analysis, which were conducted according to the guidelines of Preferred Reporting Items for Systematic Review and Meta-Analysis, 1092 articles were screened from four databases of which 47 studies fulfilled the selected criteria. By performing a random-effect model, the pooled prevalence of nosocomial multidrug-resistant <i>K. pneumoniae</i> was estimated at 32.8% (95% CI, 23.6–43.6), with high heterogeneity (I<sup>2</sup> 98.29%, <i>p</i>-value &lt; 0.001). The estimated prevalence of this pathogen and a few related studies were discussed, raising awareness of the spread of multidrug-resistant <i>K. pneumoniae</i> in the healthcare setting. The emergence of nosocomial multidrug-resistant <i>K. pneumoniae</i> is expected to increase globally in the future, and the best treatments for treating and preventing this pathogen should be acknowledged by healthcare staff. Full article </div> </div> <div > (This article belongs to the Special Issue Healthcare Infections, Healthcare Environment and Antimicrobial Resistance) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 670 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> A Closer Look at Dexamethasone and the SARS-CoV-2-Induced Cytokine Storm: In Silico Insights of the First Life-Saving COVID-19 Drug <div > by <span ><div >Paul Morgan</div>, </span><span ><div >Shareen J. Arnold</div>, </span><span ><div >Nai-Wan Hsiao</div> and </span><span ><div >Chih-Wen Shu</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1507; https://doi.org/10.3390/antibiotics10121507 - 08 Dec 2021 </div> <div > Abstract <div > The term cytokine storm refers to an uncontrolled overproduction of soluble inflammatory markers known as cytokines and chemokines. Autoimmune destruction of the lungs triggered by the release of these inflammatory markers often induces acute respiratory distress syndrome (ARDS). ARDS is an emergency condition [...] Read more. </div> <div > The term cytokine storm refers to an uncontrolled overproduction of soluble inflammatory markers known as cytokines and chemokines. Autoimmune destruction of the lungs triggered by the release of these inflammatory markers often induces acute respiratory distress syndrome (ARDS). ARDS is an emergency condition with a high mortality rate in COVID-19 patients. Dexamethasone is the first repurposed corticosteroid with life-saving efficacy in patients with severe SARS-CoV-2 infection. Dexamethasone has traditionally been known to suppress the production of inflammatory markers at the transcriptional level, but its role as a direct therapeutic to neutralize cytokines, chemokines, their receptors, and functionally critical SARS-CoV-2 proteins has not yet been explored. Herein, we demonstrated that dexamethasone binds with high affinity to interlukin-1 (IL-1), IL-6, IL-8, IL-12, IL-21, INF2, TGFβ-1, INF-γ, CXCL8, some of the receptors, IL-1R, IL-21R, IFNGR, INFAR, IL-6αR-gp130, ST2 and the SARS-CoV-2 protein NSP macro X, and 3CLpro, forming stable drug–protein complexes. Our work implied that dexamethasone has the potential to directly neutralize inflammatory markers, further supporting its life-saving potential in patients with severe manifestations of COVID-19. Full article </div> </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline <div > by <span ><div >Béla Kocsis</div>, </span><span ><div >Dániel Gulyás</div> and </span><span ><div >Dóra Szabó</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1506; https://doi.org/10.3390/antibiotics10121506 - 08 Dec 2021 </div> <div > Abstract <div > Novel antimicrobial agents, approved for clinical use in past years, represent potential treatment options for various infections. In this review, we summarize the most important medical and microbiological features of three recently approved fluoroquinolones, namely delafloxacin, finafloxacin, and zabofloxacin. Delafloxacin possesses an anionic [...] Read more. </div> <div > Novel antimicrobial agents, approved for clinical use in past years, represent potential treatment options for various infections. In this review, we summarize the most important medical and microbiological features of three recently approved fluoroquinolones, namely delafloxacin, finafloxacin, and zabofloxacin. Delafloxacin possesses an anionic chemical structure, and represents broad-spectrum activity, as it targets both bacterial DNA gyrase and topoisomerase IV enzymes of gram-positive and gram-negative bacteria with equal affinity. Its molecular surface is larger than that of other fluoroquinolones, and it has enhanced antibacterial efficacy in acidic environments. Delafloxacin has been approved to treat acute bacterial skin and skin-structure infections, as well as community-acquired bacterial pneumonia. Finafloxacin has a zwitterionic chemical structure, and targets both DNA gyrase and topoisomerase IV enzymes. This enables a broad antibacterial spectrum; however, finafloxacin has so far only been approved in ear-drops to treat bacterial otitis externa. Zabofloxacin is also a broad-spectrum fluoroquinolone agent, and was first approved in South Korea to treat acute bacterial exacerbation of chronic obstructive pulmonary disease. The introduction of these novel fluoroquinolones into daily practice extends the possible indications of antibiotics into different bacterial infections, and provides treatment options in difficult-to-treat infections. However, some reports of delafloxacin resistance have already appeared, thus underlining the importance of the prudent use of antibiotics. Full article </div> </div> <div > (This article belongs to the Special Issue 10th Anniversary of Antibiotics - Recent Advances in Novel Antimicrobial Agents) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Alkaloids as Photosensitisers for the Inactivation of Bacteria <div > by <span ><div >Sònia López-Molina</div>, </span><span ><div >Cristina Galiana-Roselló</div>, </span><span ><div >Carolina Galiana</div>, </span><span ><div >Ariadna Gil-Martínez</div>, </span><span ><div >Stephane Bandeira</div> and </span><span ><div >Jorge González-García</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1505; https://doi.org/10.3390/antibiotics10121505 - 08 Dec 2021 </div> <div > Abstract <div > Antimicrobial photodynamic therapy has emerged as a powerful approach to tackle microbial infections. Photodynamic therapy utilises a photosensitiser, light, and oxygen to generate singlet oxygen and/or reactive oxygen species in an irradiated tissue spot, which subsequently react with nearby biomolecules and destroy the [...] Read more. </div> <div > Antimicrobial photodynamic therapy has emerged as a powerful approach to tackle microbial infections. Photodynamic therapy utilises a photosensitiser, light, and oxygen to generate singlet oxygen and/or reactive oxygen species in an irradiated tissue spot, which subsequently react with nearby biomolecules and destroy the cellular environment. Due to the possibility to irradiate in a very precise location, it can be used to eradicate bacteria, fungus, and parasites upon light activation of the photosensitiser. In this regard, natural products are low-cost molecules capable of being obtained in large quantities, and some of them can be used as photosensitisers. Alkaloids are the largest family among natural products and include molecules with a basic nature and aromatic rings. For this study, we collected the naturally occurring alkaloids used to treat microorganism infections using a photodynamic inactivation approach. We gathered their main photophysical properties (excitation/emission wavelengths, quantum yields, and oxygen quantum yield) which characterise the ability to efficiently photosensitise. In addition, we described the antibacterial activity of alkaloids upon irradiation and the mechanisms involved in the microorganism killing. This review will serve as a reference source to obtain the main information on alkaloids used in antimicrobial photodynamic therapy. Full article </div> </div> <div > (This article belongs to the Special Issue Search of New Natural Products with Antimicrobial Activity) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 1230 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Analysis of Plant Origin Antibiotics against Oral Bacterial Infections Using In Vitro and In Silico Techniques and Characterization of Active Constituents <div > by <span ><div >Abdul Rafey</div>, </span><span ><div >Adnan Amin</div>, </span><span ><div >Muhammad Kamran</div>, </span><span ><div >Uzma Haroon</div>, </span><span ><div >Kainat Farooq</div>, </span><span ><div >Kenn Foubert</div> and </span><span ><div >Luc Pieters</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1504; https://doi.org/10.3390/antibiotics10121504 - 08 Dec 2021 </div> <div > Abstract <div > The pervasiveness of oral bacterial infections in diabetic patients is a serious health concern that may produce severe complications. We investigated 26 Ayurvedic medicinal plants traditionally used for treatment of the oral bacterial infections with the aim to look for new promising drug [...] Read more. </div> <div > The pervasiveness of oral bacterial infections in diabetic patients is a serious health concern that may produce severe complications. We investigated 26 Ayurvedic medicinal plants traditionally used for treatment of the oral bacterial infections with the aim to look for new promising drug leads that can be further employed for herbal formulation design. The plants were grouped into three categories based on traditional usage. All plant extracts were examined for antibacterial, antibiofilm and antiquorum-sensing properties. The plants with significant activities including <i>Juglans regia</i>, <i>Syzygium aromaticum</i>, <i>Eruca sativa</i>, <i>Myristica fragrans</i>, <i>Punica granatum</i> and <i>Azadirachta indica</i> were further analyzed using HPLC-DAD-QToF and GC-MS. In silico and in vitro activity was evaluated for selected constituents. Finally, it could be concluded that eugenol and 2-phenylethylisothiocyanate are major contributors towards inhibition of bacterial biofilms and quorum sensing. Full article </div> </div> <div > (This article belongs to the Special Issue Design and Preparation of Antimicrobial Agents) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Comparative Study of Antimicrobial Properties of Bee Venom Extracts and Melittins of Honey Bees <div > by <span ><div >Jakkrawut Maitip</div>, </span><span ><div >Wannapha Mookhploy</div>, </span><span ><div >Supharerk Khorndork</div> and </span><span ><div >Panuwan Chantawannakul</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1503; https://doi.org/10.3390/antibiotics10121503 - 08 Dec 2021 </div> <div > Abstract <div > Bee venom (BV), or apitoxin, is a complex substance produced by a gland in the abdominal cavity of bees. The main component of BV is melittin, which is a largely studied substance due to its biological properties. To date, the most well-known bee [...] Read more. </div> <div > Bee venom (BV), or apitoxin, is a complex substance produced by a gland in the abdominal cavity of bees. The main component of BV is melittin, which is a largely studied substance due to its biological properties. To date, the most well-known bee venom and melittin are derived from domesticated honey bees, while venom and melittin derived from wild honey bees have been under-investigated. Hence, this study primarily reports the antimicrobial activities of bee venom and synthetic melittin derived from four different honey bee species (<i>Apis mellifera</i>, <i>A. cerana, A. dorsata</i>, and <i>A. florea</i>) in Thailand. All the bee venom extracts and melittins showed more robust antibacterial activities against Gram-positive (<i>Bacillus subtilis</i>, <i>Micrococcus luteus</i>, <i>Staphylococcus aureus</i>, <i>S. aureus MRSA</i>, and <i>S. epidermidis</i>) than Gram-negative bacteria (<i>Escherichia coli</i>, <i>Klebsiella pneuminiae</i>, and <i>Salmonella typhimurium</i>) or a fungus (<i>Candida albicans</i>), while the synthetic melittins also have antimicrobial activity at higher concentrations than the bee venom extract. Furthermore, the <i>A. cerana</i> venom extract showed the highest activity against the tested bacteria, followed by <i>A. mellifera</i>, <i>A. florea,</i> and <i>A. dorsata</i>. Therefore, <i>A. cerana</i> venom may be further developed for use in medical applications as a potential alternative agent against Gram-positive bacteria and antibiotic-resistant bacteria. Full article </div> </div> <div > (This article belongs to the Special Issue Novel Antibiotics and Novel Modes of Action to Fight Infectious Diseases in Antimicrobial Resistance Era) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition <div > by <span ><div >Abolfazl Dashtbani-Roozbehani</div> and </span><span ><div >Melissa H. Brown</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1502; https://doi.org/10.3390/antibiotics10121502 - 07 Dec 2021 </div> <div > Abstract <div > The increasing emergence of antimicrobial resistance in staphylococcal bacteria is a major health threat worldwide due to significant morbidity and mortality resulting from their associated hospital- or community-acquired infections. Dramatic decrease in the discovery of new antibiotics from the pharmaceutical industry coupled with [...] Read more. </div> <div > The increasing emergence of antimicrobial resistance in staphylococcal bacteria is a major health threat worldwide due to significant morbidity and mortality resulting from their associated hospital- or community-acquired infections. Dramatic decrease in the discovery of new antibiotics from the pharmaceutical industry coupled with increased use of sanitisers and disinfectants due to the ongoing COVID-19 pandemic can further aggravate the problem of antimicrobial resistance. Staphylococci utilise multiple mechanisms to circumvent the effects of antimicrobials. One of these resistance mechanisms is the export of antimicrobial agents through the activity of membrane-embedded multidrug efflux pump proteins. The use of efflux pump inhibitors in combination with currently approved antimicrobials is a promising strategy to potentiate their clinical efficacy against resistant strains of staphylococci, and simultaneously reduce the selection of resistant mutants. This review presents an overview of the current knowledge of staphylococcal efflux pumps, discusses their clinical impact, and summarises compounds found in the last decade from plant and synthetic origin that have the potential to be used as adjuvants to antibiotic therapy against multidrug resistant staphylococci. Critically, future high-resolution structures of staphylococcal efflux pumps could aid in design and development of safer, more target-specific and highly potent efflux pump inhibitors to progress into clinical use. Full article </div> </div> <div > (This article belongs to the Special Issue Antibacterial, Antibiofilm and Anti-virulence Activity Research of Both Natural and Synthetic Products) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 313 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> <a >Influence of Nisin-Biogel at Subinhibitory Concentrations on Virulence Expression in <i>Staphylococcus aureus</i> Isolates from Diabetic Foot Infections</a> <div > by <span ><div >Carolina Jesus</div>, </span><span ><div >Rui Soares</div>, </span><span ><div >Eva Cunha</div>, </span><span ><div >Miguel Grilo</div>, </span><span ><div >Luís Tavares</div> and </span><span ><div >Manuela Oliveira</div></span> </div> <div > Antibiotics <b>2021</b>, 10(12), 1501; https://doi.org/10.3390/antibiotics10121501 - 07 Dec 2021 </div> <div > Abstract <div > A new approach to diabetic foot infections (DFIs) has been investigated, using a nisin-biogel combining the antimicrobial peptide (AMP) nisin with the natural polysaccharide guar-gum. Since in in vivo conditions bacteria may be exposed to decreased antimicrobial concentrations, known as subinhibitory concentrations (sub-MICs), [...] Read more. </div> <div > A new approach to diabetic foot infections (DFIs) has been investigated, using a nisin-biogel combining the antimicrobial peptide (AMP) nisin with the natural polysaccharide guar-gum. Since in in vivo conditions bacteria may be exposed to decreased antimicrobial concentrations, known as subinhibitory concentrations (sub-MICs), effects of nisin-biogel sub-MIC values corresponding to 1/2, 1/4 and 1/8 of nisin’s minimum inhibitory concentration (MIC) on virulence expression by six <i>Staphylococcus aureus</i> DFI isolates was evaluated by determining bacteria growth rate; expression of genes encoding for staphylococcal protein A (<i>spA</i>), coagulase (<i>coa</i>), clumping factor A (<i>clfA</i>), autolysin (<i>atl</i>), intracellular adhesin A (<i>icaA</i>), intracellular adhesin D (<i>icaD</i>), and the accessory gene regulator I (<i>agrI</i>); biofilm formation; Coa production; and SpA release. Nisin-biogel sub-MICs decreased bacterial growth in a strain- and dose-dependent manner, decreased <i>agrI</i>, <i>atl</i> and <i>clfA</i> expression, and increased <i>spA</i>, <i>coa</i>, <i>icaA</i> and <i>icaD</i> expression. Biofilm formation increased in the presence of nisin-biogel at 1/4 and 1/8 MIC, whereas 1/2 MIC had no effect. Finally, nisin-biogel at sub-MICs did not affect coagulase production, but decreased SpA production in a dose-dependent manner. Results highlight the importance of optimizing nisin-biogel doses before proceeding to in vivo trials, to reduce the risk of virulence factor’s up-regulation due to the presence of inappropriate antimicrobial concentrations. Full article </div> </div> <div > (This article belongs to the Special Issue Antimicrobial Resistance and Virulence - 2nd Volume) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> </div> <div > More Articles... </div> </div> </div> </div> <div > <div > <div > <div > <a > Submit to <i>Antibiotics</i> </a> Review for Antibiotics <div > Share </div> </div> <div > <h2 >Journal Menu</h2> ► ▼ Journal Menu <ul > <li > <ul> <li > Antibiotics Home </li> <li > Aims Scope </li> <li > Editorial Board </li> <li > Reviewer Board </li> <li > Topical Advisory Panel </li> <li > Instructions for Authors </li> <li > Special Issues </li> <li > Sections Collections </li> <li > Article Processing Charge </li> <li > Indexing Archiving </li> <li > Editor's Choice Articles </li> <li > Most Cited Viewed </li> <li > Journal Statistics </li> <li > Journal History </li> <li > Journal Awards </li> <li > Conferences </li> <li > Editorial Office </li> <li > 10th Anniversary of Antibiotics </li> </ul> </li> </ul> </div> <h2 >Journal Browser</h2> ► ▼ Journal Browser <div > <div > <ul > <li > <a > <i > arrow_forward_ios </i> Forthcoming issue </a> <a > <i > arrow_forward_ios </i> Current issue </a> </li> <div > <div > <div > <li > Vol. 10 (2021) </li> <li > Vol. 9 (2020) </li> <li > Vol. 8 (2019) </li> <li > Vol. 7 (2018) </li> <li > Vol. 6 (2017) </li> <li > Vol. 5 (2016) </li> <li > Vol. 4 (2015) </li> <li > Vol. 3 (2014) </li> <li > Vol. 2 (2013) </li> <li > Vol. 1 (2012) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div > <div > <h2>Highly Accessed Articles</h2> </div> <div > <div > View More... </div> </div> </div> <div > <div > <h2>Latest Books</h2> </div> <div > <div > More Open Access Books... </div> </div> </div> </div> <div > <div > <div > <h2>E-Mail Alert</h2> </div> </div> <div > <div > <h2>News</h2> </div> <div > <div > 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div > 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div > 25 October 2021 Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October </div> <div > More News Announcements... </div> </div> </div> <div > <div > <h2>Topics</h2> </div> <div > <div ><div> Topic in Applied Sciences, Biomolecules, Pharmaceuticals, Biomedicines, Antibiotics</div> Compounds with Medicinal Value Editor-in-Chief: Maria Stefania SinicropiDeadline: 31 March 2022</div> <div ><div> Topic in Antibiotics, Pharmaceutics, Pharmaceuticals, MPs</div> Emerging Material-Based Approaches to Chronic and Infectious Diseases Editor-in-Chief: Alan J. HibbittsDeadline: 31 May 2022</div> <div ><div> Topic in Antibiotics, Antioxidants, JoF, Microbiology Research, Microorganisms</div> Redox in Microorganisms Deadline: 30 November 2022</div> </div> </div> <div > <div > <h2>Conferences</h2> </div> <div > <div > Announce Your Conference </div> <div > 16–18 February 2022 3rd MMCS: Shaping Medicinal Chemistry for the New Decade</div> <div > 7–9 November 2022 7th International Symposium on Antimicrobial Peptides – AMP 2022</div> <div > More Conferences... </div> </div> </div> <div > <div > <h2>Special Issues</h2> </div> <div > <div > Edit a Special Issue </div> <div ><div> Special Issue in Antibiotics</div> Antimicrobial Susceptibility and Clinical Findings of Anaerobic Bacteria Guest Editor: Fernando CoboDeadline: 15 December 2021</div> <div ><div> Special Issue in Antibiotics</div> Spread of Multidrug-Resistant Microorganisms Guest Editors: Teresa Fasciana, Mara Di Giulio, Silvia Di Lodovico, Alberto AntonelliDeadline: 31 December 2021</div> <div ><div> Special Issue in Antibiotics</div> Pharmacokinetic/Pharmacodynamic Models of Antibiotics Guest Editors: Andrew David Berti, Razieh KebriaeiDeadline: 5 January 2022</div> <div ><div> Special Issue in Antibiotics</div> Antibiotic Use in Clinical Infection: How to Reinvent Old Molecules and How to Squeeze Out New Ones Guest Editor: Stefano Di BellaDeadline: 31 January 2022</div> <div > More Special Issues </div> </div> </div> <div > <div > <h2>Topical Collections</h2> </div> <div > <div ><div> Topical Collection in Antibiotics</div> Discovery and MultiFunctionality of Anti-Microbial Peptides Collection Editors: Marc Maresca, Josette Perrier, Michael Lafond</div> <div ><div> Topical Collection in Antibiotics</div> Antimicrobial Resistance and Anti-Biofilms Collection Editors: Ding-Qiang Chen, Yulong Tan, Ren-You Gan, Zhenbo Xu, Junyan Liu</div> </div> </div> <div > <div > <h2>Jobs in Research</h2> </div> <div > <div > Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div > <div > Antibiotics, EISSN 2079-6382, Published by MDPI <span> Disclaimer <div > The statements, opinions and data contained in the journal Antibiotics are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div > RSS Content Alert </div> </div> <div > <div > <h3> Further Information </h3> Article Processing Charges Pay an Invoice <a > Open Access Policy </a> <a > Contact MDPI </a> <a > Jobs at MDPI </a> </div> <div > <h3> Guidelines </h3> <a > For Authors </a> <a > For Reviewers </a> <a > For Editors </a> <a > For Librarians </a> <a > For Publishers </a> <a > For Societies </a> </div> <div > <h3> MDPI Initiatives </h3> <a > Sciforum </a> <a > MDPI Books </a> <a > Preprints </a> <a > Scilit </a> <a > SciProfiles </a> <a > Encyclopedia </a> <a > JAMS </a> <a > Proceedings Series </a> </div> <div > <h3> Follow MDPI </h3> <a > LinkedIn </a> <a > Facebook </a> <a > Twitter </a> </div> </div> <div > <div > <div > © 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div > <a > Disclaimer </a> <div > The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a > Terms and Conditions </a> <a > Privacy Policy </a> </div> </div> </div> </div> <div > <div > We use cookies on our website to ensure you get the best experience. Read more about our cookies <a >here</a>. </div> <div > <a >Accept</a> </div> </div> <div > <div > We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div > <a >Never show this again</a> </div> </div> </div> <div > <div > <div > <h2 >Share Link</h2> </div> <div > <a >Copy</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Share</h2> </div> </div> <a > <i >clear</i> </a> </div> <a >Back to TopTop</a> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <a class="valid" valid="valid" title="valid: True, node: 5, tag: a, level: 5" node_number="5"> <h2 class="valid" valid="valid" title="valid: True, node: 6, tag: h2, level: 6" node_number="6">25th Anniversary</h2> </a> <a class="valid" valid="valid" title="valid: True, node: 7, tag: a, level: 5" node_number="7"> <h2 class="valid" valid="valid" title="valid: True, node: 8, tag: h2, level: 6" node_number="8">Journals</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 5" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 6" node_number="10"> <h2 class="valid" valid="valid" title="valid: True, node: 11, tag: h2, level: 7" node_number="11">Information</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 12, tag: div, level: 6" node_number="12"> <div class="valid" valid="valid" title="valid: True, node: 13, tag: div, level: 7" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 8" node_number="14"> <a class="valid" valid="valid" title="valid: True, node: 15, tag: a, level: 9" node_number="15">For Authors</a> <a class="valid" valid="valid" title="valid: True, node: 16, tag: a, level: 9" node_number="16">For Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 17, tag: a, level: 9" node_number="17">For Editors</a> <a class="valid" valid="valid" title="valid: True, node: 18, tag: a, level: 9" node_number="18">For Librarians</a> <a class="valid" valid="valid" title="valid: True, node: 19, tag: a, level: 9" node_number="19">For Publishers</a> <a class="valid" valid="valid" title="valid: True, node: 20, tag: a, level: 9" node_number="20">For Societies</a> </div> <div class="valid" valid="valid" title="valid: True, node: 21, tag: div, level: 8" node_number="21"> <a class="valid" valid="valid" title="valid: True, node: 22, tag: a, level: 9" node_number="22">Article Processing Charges</a> <a class="valid" valid="valid" title="valid: True, node: 23, tag: a, level: 9" node_number="23">Open Access Policy</a> <a class="valid" valid="valid" title="valid: True, node: 24, tag: a, level: 9" node_number="24">Institutional Open Access Program</a> <a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 9" node_number="25">Editorial Process</a> <a class="valid" valid="valid" title="valid: True, node: 26, tag: a, level: 9" node_number="26">Awards</a> <a class="valid" valid="valid" title="valid: True, node: 27, tag: a, level: 9" node_number="27">Research and Publication Ethics</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 28, tag: a, level: 5" node_number="28"> <h2 class="valid" valid="valid" title="valid: True, node: 29, tag: h2, level: 6" node_number="29">Author Services</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 5" node_number="30"> <div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 6" node_number="31"> <h2 class="valid" valid="valid" title="valid: True, node: 32, tag: h2, level: 7" node_number="32">Initiatives</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 33, tag: div, level: 6" node_number="33"> <div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 7" node_number="34"> <div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 8" node_number="35"> <a class="valid" valid="valid" title="valid: True, node: 36, tag: a, level: 9" node_number="36">Sciforum</a> <a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 9" node_number="37">MDPI Books</a> <a class="valid" valid="valid" title="valid: True, node: 38, tag: a, level: 9" node_number="38">Preprints</a> <a class="valid" valid="valid" title="valid: True, node: 39, tag: a, level: 9" node_number="39">Scilit</a> <a class="valid" valid="valid" title="valid: True, node: 40, tag: a, level: 9" node_number="40">SciProfiles</a> <a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 9" node_number="41">Encyclopedia</a> <a class="valid" valid="valid" title="valid: True, node: 42, tag: a, level: 9" node_number="42">JAMS</a> <a class="valid" valid="valid" title="valid: True, node: 43, tag: a, level: 9" node_number="43">Proceedings Series</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 44, tag: a, level: 5" node_number="44"> <h2 class="valid" valid="valid" title="valid: True, node: 45, tag: h2, level: 6" node_number="45">About</h2> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 4" node_number="46"> <a class="valid" valid="valid" title="valid: True, node: 47, tag: a, level: 5" node_number="47">Sign In / Sign Up</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 2" node_number="48"> <h2 class="valid" valid="valid" title="valid: True, node: 49, tag: h2, level: 3" node_number="49">Notice</h2> <a class="valid" valid="valid" title="valid: True, node: 50, tag: a, level: 3" node_number="50"> <i class="valid" valid="valid" title="valid: True, node: 51, tag: i, level: 4" node_number="51">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 2" node_number="52"> <div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 3" node_number="53"> <div class="valid" valid="valid" title="valid: True, node: 54, tag: div, level: 4" node_number="54"> <h2 class="valid" valid="valid" title="valid: True, node: 55, tag: h2, level: 5" node_number="55">Notice</h2> <p class="valid" valid="valid" title="valid: True, node: 56, tag: p, level: 5" node_number="56"> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 57, tag: div, level: 3" node_number="57"> <div class="valid" valid="valid" title="valid: True, node: 58, tag: div, level: 4" node_number="58"> <a class="valid" valid="valid" title="valid: True, node: 59, tag: a, level: 5" node_number="59">Continue</a> <a class="valid" valid="valid" title="valid: True, node: 60, tag: a, level: 5" node_number="60">Cancel</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 61, tag: a, level: 3" node_number="61"> <i class="valid" valid="valid" title="valid: True, node: 62, tag: i, level: 4" node_number="62">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 63, tag: div, level: 2" node_number="63"> <p class="valid" valid="valid" title="valid: True, node: 64, tag: p, level: 3" node_number="64"> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 65, tag: div, level: 2" node_number="65"> <p class="valid" valid="valid" title="valid: True, node: 66, tag: p, level: 3" node_number="66"> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p class="valid" valid="valid" title="valid: True, node: 67, tag: p, level: 3" node_number="67"> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 2" node_number="68"> <p class="valid" valid="valid" title="valid: True, node: 69, tag: p, level: 3" node_number="69"> Editor&#8217;s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 70, tag: div, level: 2" node_number="70"> <div class="valid" valid="valid" title="valid: True, node: 71, tag: div, level: 3" node_number="71">  </div> <section class="valid" valid="valid" title="valid: True, node: 72, tag: section, level: 3" node_number="72"> <header class="valid" valid="valid" title="valid: True, node: 73, tag: header, level: 4" node_number="73"> <div class="valid" valid="valid" title="valid: True, node: 74, tag: div, level: 5" node_number="74"> <div class="valid" valid="valid" title="valid: True, node: 75, tag: div, level: 6" node_number="75"> <div class="valid" valid="valid" title="valid: True, node: 76, tag: div, level: 7" node_number="76"> <ul class="valid" valid="valid" title="valid: True, node: 77, tag: ul, level: 8" node_number="77"> <li class="valid" valid="valid" title="valid: True, node: 78, tag: li, level: 9" node_number="78"> <a class="valid" valid="valid" title="valid: True, node: 79, tag: a, level: 10" node_number="79">25th Anniversary</a> </li> <li class="valid" valid="valid" title="valid: True, node: 80, tag: li, level: 9" node_number="80"> <a class="valid" valid="valid" title="valid: True, node: 81, tag: a, level: 10" node_number="81">Journals</a> </li> <li class="valid" valid="valid" title="valid: True, node: 82, tag: li, level: 9" node_number="82"> <a class="valid" valid="valid" title="valid: True, node: 83, tag: a, level: 10" node_number="83">Information</a> <ul class="valid" valid="valid" title="valid: True, node: 84, tag: ul, level: 10" node_number="84"> <li class="valid" valid="valid" title="valid: True, node: 85, tag: li, level: 11" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 12" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 13" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 14" node_number="88"> <li title="valid: False, node: 89, tag: li, level: 15" node_number="89"> <a title="valid: False, node: 90, tag: a, level: 16" node_number="90">For Authors</a> </li> <li title="valid: False, node: 91, tag: li, level: 15" node_number="91"> <a title="valid: False, node: 92, tag: a, level: 16" node_number="92">For Reviewers</a> </li> <li title="valid: False, node: 93, tag: li, level: 15" node_number="93"> <a title="valid: False, node: 94, tag: a, level: 16" node_number="94">For Editors</a> </li> <li title="valid: False, node: 95, tag: li, level: 15" node_number="95"> <a title="valid: False, node: 96, tag: a, level: 16" node_number="96">For Librarians</a> </li> <li title="valid: False, node: 97, tag: li, level: 15" node_number="97"> <a title="valid: False, node: 98, tag: a, level: 16" node_number="98">For Publishers</a> </li> <li title="valid: False, node: 99, tag: li, level: 15" node_number="99"> <a title="valid: False, node: 100, tag: a, level: 16" node_number="100">For Societies</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 101, tag: div, level: 13" node_number="101"> <ul class="valid" valid="valid" title="valid: True, node: 102, tag: ul, level: 14" node_number="102"> <li title="valid: False, node: 103, tag: li, level: 15" node_number="103"> <a title="valid: False, node: 104, tag: a, level: 16" node_number="104">Article Processing Charges</a> </li> <li title="valid: False, node: 105, tag: li, level: 15" node_number="105"> <a title="valid: False, node: 106, tag: a, level: 16" node_number="106">Open Access Policy</a> </li> <li title="valid: False, node: 107, tag: li, level: 15" node_number="107"> <a title="valid: False, node: 108, tag: a, level: 16" node_number="108">Institutional Open Access Program</a> </li> <li title="valid: False, node: 109, tag: li, level: 15" node_number="109"> <a title="valid: False, node: 110, tag: a, level: 16" node_number="110">Editorial Process</a> </li> <li title="valid: False, node: 111, tag: li, level: 15" node_number="111"> <a title="valid: False, node: 112, tag: a, level: 16" node_number="112">Awards</a> </li> <li title="valid: False, node: 113, tag: li, level: 15" node_number="113"> <a title="valid: False, node: 114, tag: a, level: 16" node_number="114">Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 115, tag: li, level: 9" node_number="115"> <a class="valid" valid="valid" title="valid: True, node: 116, tag: a, level: 10" node_number="116">Author Services</a> </li> <li class="valid" valid="valid" title="valid: True, node: 117, tag: li, level: 9" node_number="117"> <a class="valid" valid="valid" title="valid: True, node: 118, tag: a, level: 10" node_number="118">Initiatives</a> <ul class="valid" valid="valid" title="valid: True, node: 119, tag: ul, level: 10" node_number="119"> <li class="valid" valid="valid" title="valid: True, node: 120, tag: li, level: 11" node_number="120"> <div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 12" node_number="121"> <div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 13" node_number="122"> <ul class="valid" valid="valid" title="valid: True, node: 123, tag: ul, level: 14" node_number="123"> <li title="valid: False, node: 124, tag: li, level: 15" node_number="124"> <a title="valid: False, node: 125, tag: a, level: 16" node_number="125"> Sciforum </a> </li> <li title="valid: False, node: 126, tag: li, level: 15" node_number="126"> <a title="valid: False, node: 127, tag: a, level: 16" node_number="127"> MDPI Books </a> </li> <li title="valid: False, node: 128, tag: li, level: 15" node_number="128"> <a title="valid: False, node: 129, tag: a, level: 16" node_number="129"> Preprints </a> </li> <li title="valid: False, node: 130, tag: li, level: 15" node_number="130"> <a title="valid: False, node: 131, tag: a, level: 16" node_number="131"> Scilit </a> </li> <li title="valid: False, node: 132, tag: li, level: 15" node_number="132"> <a title="valid: False, node: 133, tag: a, level: 16" node_number="133"> SciProfiles </a> </li> <li title="valid: False, node: 134, tag: li, level: 15" node_number="134"> <a title="valid: False, node: 135, tag: a, level: 16" node_number="135"> Encyclopedia </a> </li> <li title="valid: False, node: 136, tag: li, level: 15" node_number="136"> <a title="valid: False, node: 137, tag: a, level: 16" node_number="137"> JAMS </a> </li> <li title="valid: False, node: 138, tag: li, level: 15" node_number="138"> <a title="valid: False, node: 139, tag: a, level: 16" node_number="139"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 140, tag: li, level: 9" node_number="140"> <a class="valid" valid="valid" title="valid: True, node: 141, tag: a, level: 10" node_number="141">About</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 7" node_number="142"> <div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 8" node_number="143"> <a class="valid" valid="valid" title="valid: True, node: 144, tag: a, level: 9" node_number="144">Sign In / Sign Up</a> <a class="valid" valid="valid" title="valid: True, node: 145, tag: a, level: 9" node_number="145">Submit</a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 146, tag: div, level: 5" node_number="146"> <div class="valid" valid="valid" title="valid: True, node: 147, tag: div, level: 6" node_number="147"> <div class="valid" valid="valid" title="valid: True, node: 148, tag: div, level: 7" node_number="148"> <div class="valid" valid="valid" title="valid: True, node: 149, tag: div, level: 8" node_number="149"> <a class="valid" valid="valid" title="valid: True, node: 150, tag: a, level: 9" node_number="150"> Covered in: PubMed </a> </div></div> <div class="valid" valid="valid" title="valid: True, node: 151, tag: div, level: 7" node_number="151"> <div class="valid" valid="valid" title="valid: True, node: 152, tag: div, level: 8" node_number="152"> <a class="valid" valid="valid" title="valid: True, node: 153, tag: a, level: 9" node_number="153"> IMPACTFACTOR 4.639 </a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 154, tag: div, level: 6" node_number="154"> Journals </div> <div class="valid" valid="valid" title="valid: True, node: 155, tag: div, level: 6" node_number="155"> Antibiotics </div> </div> </header> <div class="valid" valid="valid" title="valid: True, node: 156, tag: div, level: 4" node_number="156"> <div class="valid" valid="valid" title="valid: True, node: 157, tag: div, level: 5" node_number="157"> <div class="valid" valid="valid" title="valid: True, node: 158, tag: div, level: 6" node_number="158"> <div class="valid" valid="valid" title="valid: True, node: 159, tag: div, level: 7" node_number="159"> <div class="valid" valid="valid" title="valid: True, node: 160, tag: div, level: 8" node_number="160"> <ul class="valid" valid="valid" title="valid: True, node: 161, tag: ul, level: 9" node_number="161"> <li class="valid" valid="valid" title="valid: True, node: 162, tag: li, level: 10" node_number="162"> <a class="valid" valid="valid" title="valid: True, node: 163, tag: a, level: 11" node_number="163"> <div class="valid" valid="valid" title="valid: True, node: 164, tag: div, level: 12" node_number="164"> Non-Typhoidal Salmonella Infection in Children: Influence of Antibiotic Therapy on Postconvalescent Excretion and Clinical Course&#8212;A Systematic Review </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 165, tag: li, level: 10" node_number="165"> <a class="valid" valid="valid" title="valid: True, node: 166, tag: a, level: 11" node_number="166"> <div class="valid" valid="valid" title="valid: True, node: 167, tag: div, level: 12" node_number="167"> Implementation of a Cellulitis Management Plan in Three Australian Regional Health Services to Address an Evidence&#8211;Practice Gap in Antibiotic Prescribing </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 168, tag: li, level: 10" node_number="168"> <a class="valid" valid="valid" title="valid: True, node: 169, tag: a, level: 11" node_number="169"> <div class="valid" valid="valid" title="valid: True, node: 170, tag: div, level: 12" node_number="170"> FtsH Sensitizes Methicillin-Resistant Staphylococcus aureus to &#946;-Lactam Antibiotics by Degrading YpfP, a Lipoteichoic Acid Synthesis Enzyme </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 171, tag: li, level: 10" node_number="171"> <a class="valid" valid="valid" title="valid: True, node: 172, tag: a, level: 11" node_number="172"> <div class="valid" valid="valid" title="valid: True, node: 173, tag: div, level: 12" node_number="173"> Probiotics and Gut Antimicrobial-Resistant Enterobacterales </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 174, tag: li, level: 10" node_number="174"> <a class="valid" valid="valid" title="valid: True, node: 175, tag: a, level: 11" node_number="175"> <div class="valid" valid="valid" title="valid: True, node: 176, tag: div, level: 12" node_number="176"> Earliest examples of Colistin Resistance Gene mcr-1 reported in Europe </div> </a> </li> </ul> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 177, tag: div, level: 7" node_number="177"> <div class="valid" valid="valid" title="valid: True, node: 178, tag: div, level: 8" node_number="178"> <h2 class="valid" valid="valid" title="valid: True, node: 179, tag: h2, level: 9" node_number="179">Journal Description</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 180, tag: div, level: 8" node_number="180"> <div class="valid" valid="valid" title="valid: True, node: 181, tag: div, level: 9" node_number="181"> <h1 class="valid" valid="valid" title="valid: True, node: 182, tag: h1, level: 10" node_number="182"> Antibiotics </h1> <div class="valid" valid="valid" title="valid: True, node: 183, tag: div, level: 10" node_number="183"> Antibiotics is a <a class="valid" valid="valid" title="valid: True, node: 184, tag: a, level: 11" node_number="184">peer-reviewed</a>, open access journal on all aspects of antibiotics, published monthly online by MDPI. <ul class="valid" valid="valid" title="valid: True, node: 185, tag: ul, level: 11" node_number="185"> <li class="valid" valid="valid" title="valid: True, node: 186, tag: li, level: 12" node_number="186">Open Access&#8212; free for readers, with <a class="valid" valid="valid" title="valid: True, node: 187, tag: a, level: 13" node_number="187">article processing charges (APC)</a> paid by authors or their institutions.</li> <li class="valid" valid="valid" title="valid: True, node: 188, tag: li, level: 12" node_number="188">High Visibility:&#160;indexed within <a class="valid" valid="valid" title="valid: True, node: 189, tag: a, level: 13" node_number="189">Scopus</a>, <a class="valid" valid="valid" title="valid: True, node: 190, tag: a, level: 13" node_number="190">SCIE (Web of Science)</a>, <a class="valid" valid="valid" title="valid: True, node: 191, tag: a, level: 13" node_number="191">PubMed</a>, <a class="valid" valid="valid" title="valid: True, node: 192, tag: a, level: 13" node_number="192">PMC</a>, <a class="valid" valid="valid" title="valid: True, node: 193, tag: a, level: 13" node_number="193">Embase</a>, <a class="valid" valid="valid" title="valid: True, node: 194, tag: a, level: 13" node_number="194">CAPlus / SciFinder</a>, and many <a class="valid" valid="valid" title="valid: True, node: 195, tag: a, level: 13" node_number="195">other databases</a>.</li> <li class="valid" valid="valid" title="valid: True, node: 196, tag: li, level: 12" node_number="196">Journal Rank:&#160;JCR&#160;- Q2 (Infectious Diseases) /&#160;CiteScore&#160;- Q2 (General Pharmacology, Toxicology and Pharmaceutics)</li> <li class="valid" valid="valid" title="valid: True, node: 197, tag: li, level: 12" node_number="197">Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 13.3 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2021).</li> <li class="valid" valid="valid" title="valid: True, node: 198, tag: li, level: 12" node_number="198">Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 199, tag: div, level: 10" node_number="199"> Impact Factor: 4.639 (2020) ; 5-Year Impact Factor: 4.849 (2020) </div> <div class="valid" valid="valid" title="valid: True, node: 200, tag: div, level: 10" node_number="200"> <a class="valid" valid="valid" title="valid: True, node: 201, tag: a, level: 11" node_number="201"> <i class="valid" valid="valid" title="valid: True, node: 202, tag: i, level: 12" node_number="202">subject</i> Imprint Information </a> <a class="valid" valid="valid" title="valid: True, node: 203, tag: a, level: 11" node_number="203"> <i class="valid" valid="valid" title="valid: True, node: 204, tag: i, level: 12" node_number="204">get_app</i> Journal Flyer </a> <a class="valid" valid="valid" title="valid: True, node: 205, tag: a, level: 11" node_number="205"> Open Access </a> ISSN: 2079-6382 </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 206, tag: div, level: 7" node_number="206"> <div class="valid" valid="valid" title="valid: True, node: 207, tag: div, level: 8" node_number="207"> <h2 class="valid" valid="valid" title="valid: True, node: 208, tag: h2, level: 9" node_number="208">Latest Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 209, tag: div, level: 8" node_number="209"> <div class="valid" valid="valid" title="valid: True, node: 210, tag: div, level: 9" node_number="210"> <div class="valid" valid="valid" title="valid: True, node: 211, tag: div, level: 10" node_number="211"> <div class="valid" valid="valid" title="valid: True, node: 212, tag: div, level: 11" node_number="212"> <div class="valid" valid="valid" title="valid: True, node: 213, tag: div, level: 12" node_number="213"> <a class="valid" valid="valid" title="valid: True, node: 214, tag: a, level: 13" node_number="214"> <i class="valid" valid="valid" title="valid: True, node: 215, tag: i, level: 14" node_number="215">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 216, tag: div, level: 13" node_number="216"> Supplementary material: Supplementary File 1 (ZIP, 253 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 217, tag: div, level: 12" node_number="217"> <a class="valid" valid="valid" title="valid: True, node: 218, tag: a, level: 13" node_number="218"> <i class="valid" valid="valid" title="valid: True, node: 219, tag: i, level: 14" node_number="219">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 220, tag: div, level: 12" node_number="220"> <a class="valid" valid="valid" title="valid: True, node: 221, tag: a, level: 13" node_number="221"> <i class="valid" valid="valid" title="valid: True, node: 222, tag: i, level: 14" node_number="222">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 223, tag: div, level: 13" node_number="223"> View online as: <a class="valid" valid="valid" title="valid: True, node: 224, tag: a, level: 14" node_number="224">Abstract Page</a> <a class="valid" valid="valid" title="valid: True, node: 225, tag: a, level: 14" node_number="225">Full-Text HTML</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 226, tag: div, level: 12" node_number="226">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 227, tag: a, level: 12" node_number="227">Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing <i class="valid" valid="valid" title="valid: True, node: 228, tag: i, level: 13" node_number="228">Klebsiella pneumoniae</i> in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination</a> <div class="valid" valid="valid" title="valid: True, node: 229, tag: div, level: 12" node_number="229"> by <span class="valid" valid="valid" title="valid: True, node: 230, tag: span, level: 13" node_number="230"><div class="valid" valid="valid" title="valid: True, node: 231, tag: div, level: 14" node_number="231">Alla V. Filimonova</div>, </span><span class="valid" valid="valid" title="valid: True, node: 232, tag: span, level: 13" node_number="232"><div class="valid" valid="valid" title="valid: True, node: 233, tag: div, level: 14" node_number="233">Maria V. Golikova</div>, </span><span class="valid" valid="valid" title="valid: True, node: 234, tag: span, level: 13" node_number="234"><div class="valid" valid="valid" title="valid: True, node: 235, tag: div, level: 14" node_number="235">Elena N. Strukova</div>, </span><span class="valid" valid="valid" title="valid: True, node: 236, tag: span, level: 13" node_number="236"><div class="valid" valid="valid" title="valid: True, node: 237, tag: div, level: 14" node_number="237">Yury A. Portnoy</div>, </span><span class="valid" valid="valid" title="valid: True, node: 238, tag: span, level: 13" node_number="238"><div class="valid" valid="valid" title="valid: True, node: 239, tag: div, level: 14" node_number="239">Anastasiya A. Kuznetsova</div> and </span><span class="valid" valid="valid" title="valid: True, node: 240, tag: span, level: 13" node_number="240"><div class="valid" valid="valid" title="valid: True, node: 241, tag: div, level: 14" node_number="241">Stephen H. Zinner</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 242, tag: div, level: 12" node_number="242"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 243, tag: b, level: 13" node_number="243">2021</b>, 10(12), 1520; https://doi.org/10.3390/antibiotics10121520 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 244, tag: div, level: 12" node_number="244"> Abstract <div class="valid" valid="valid" title="valid: True, node: 245, tag: div, level: 13" node_number="245"> Traditionally, the antibacterial activity of &#946;-lactam antibiotics in the presence of &#946;-lactamase inhibitors is determined at the fixed inhibitor concentration. This traditional approach does not consider the ratio of antibiotic-to-inhibitor concentrations achieved in humans. To explore whether an alternative pharmacokinetically based approach to [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 246, tag: div, level: 13" node_number="246"> Traditionally, the antibacterial activity of &#946;-lactam antibiotics in the presence of &#946;-lactamase inhibitors is determined at the fixed inhibitor concentration. This traditional approach does not consider the ratio of antibiotic-to-inhibitor concentrations achieved in humans. To explore whether an alternative pharmacokinetically based approach to estimate MICs in combinations is predictive of antimicrobial efficacy, the effects of imipenem and doripenem alone and in combination with relebactam were studied in time-kill experiments against carbapenemase-producing <i class="valid" valid="valid" title="valid: True, node: 247, tag: i, level: 14" node_number="247">Klebsiella pneumoniae</i>. The carbapenem-to-relebactam concentration ratios in time-kill assays were equal to the therapeutic 24-h area under the concentration-time curve (AUC) ratios of the drugs (1.5/1). The simulated levels of carbapenem and relebactam were equal to their concentrations achieved in humans. When effects of combined regimens were plotted against respective C/MICs, a sigmoid relationship was obtained only with MICs determined by pharmacokinetically based method. The effectiveness of both carbapenems in the presence of relebactam was comparable by the results of time-kill experiments. These findings suggest that (1) antibiotic/inhibitor MICs determined at a pharmacokinetically based concentration ratio allow an adequate assessment of carbapenem susceptibility in carbapenemase-producing <i class="valid" valid="valid" title="valid: True, node: 248, tag: i, level: 14" node_number="248">K. pneumoniae</i> strains and can be used to predict antibacterial effects; (2) in time-kill experiments, the effects of imipenem and doripenem in the presence of relebactam are comparable. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 249, tag: div, level: 12" node_number="249"> (This article belongs to the Special Issue Alternative Approaches to Treating Antimicrobial Resistant Infections) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 250, tag: div, level: 12" node_number="250"><div class="valid" valid="valid" title="valid: True, node: 251, tag: div, level: 13" node_number="251"><div class="valid" valid="valid" title="valid: True, node: 252, tag: div, level: 14" node_number="252"><p title="valid: False, node: 253, tag: p, level: 15" node_number="253">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 254, tag: div, level: 9" node_number="254"> <div class="valid" valid="valid" title="valid: True, node: 255, tag: div, level: 10" node_number="255"> <div class="valid" valid="valid" title="valid: True, node: 256, tag: div, level: 11" node_number="256"> <div class="valid" valid="valid" title="valid: True, node: 257, tag: div, level: 12" node_number="257"> <div class="valid" valid="valid" title="valid: True, node: 258, tag: div, level: 13" node_number="258"> <a class="valid" valid="valid" title="valid: True, node: 259, tag: a, level: 14" node_number="259"> <i title="valid: False, node: 260, tag: i, level: 15" node_number="260">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 261, tag: div, level: 13" node_number="261"> <a class="valid" valid="valid" title="valid: True, node: 262, tag: a, level: 14" node_number="262"> <i title="valid: False, node: 263, tag: i, level: 15" node_number="263">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 264, tag: div, level: 14" node_number="264"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 265, tag: div, level: 13" node_number="265">Open AccessReview</div> Educational Activities for Students and Citizens Supporting the One-Health Approach on Antimicrobial Resistance <div class="valid" valid="valid" title="valid: True, node: 266, tag: div, level: 13" node_number="266"> by <span class="valid" valid="valid" title="valid: True, node: 267, tag: span, level: 14" node_number="267"><div title="valid: False, node: 268, tag: div, level: 15" node_number="268">Massimiliano Marvasi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 269, tag: span, level: 14" node_number="269"><div title="valid: False, node: 270, tag: div, level: 15" node_number="270">Lilliam Casillas</div>, </span><span class="valid" valid="valid" title="valid: True, node: 271, tag: span, level: 14" node_number="271"><div title="valid: False, node: 272, tag: div, level: 15" node_number="272">Alberto Vassallo</div> and </span><span class="valid" valid="valid" title="valid: True, node: 273, tag: span, level: 14" node_number="273"><div title="valid: False, node: 274, tag: div, level: 15" node_number="274">Diane Purchase</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 275, tag: div, level: 13" node_number="275"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 276, tag: b, level: 14" node_number="276">2021</b>, 10(12), 1519; https://doi.org/10.3390/antibiotics10121519 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 277, tag: div, level: 13" node_number="277"> Abstract <div class="valid" valid="valid" title="valid: True, node: 278, tag: div, level: 14" node_number="278"> Antibiotic resistance is one of the biggest threats to global health, food security and development. Urgent action is needed at all levels of society to reduce the impact and spread of antibiotic resistance. For a more sustaining approach, education in children, college students, [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 279, tag: div, level: 14" node_number="279"> Antibiotic resistance is one of the biggest threats to global health, food security and development. Urgent action is needed at all levels of society to reduce the impact and spread of antibiotic resistance. For a more sustaining approach, education in children, college students, citizens and caregivers are essential. The One-Heath approach is a collaborative, multisectoral and transdisciplinary strategy in which, no single organizations or sector can address the issue of antimicrobial resistance at the human&#8211;environment interface alone. Within this strategy, education plays a central role. In this scoping review, we highlighted a range of learning activities on antibiotic resistance as part of the One-Health approach. In particular, those applications that can be introduced to a wide audience to help arrest the current crisis for the next generation. The review identifies a high number of teaching opportunities: board and role-play games, round tables, musicals, e-learning and environmental experiments to couple with more curricula and formal education to inform a diverse group of audiences. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 280, tag: div, level: 13" node_number="280"> (This article belongs to the Special Issue Antimicrobial Resistance and the Environment: One Health Approach) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 281, tag: div, level: 13" node_number="281"><div class="valid" valid="valid" title="valid: True, node: 282, tag: div, level: 14" node_number="282"><div title="valid: False, node: 283, tag: div, level: 15" node_number="283"><p title="valid: False, node: 284, tag: p, level: 16" node_number="284">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 285, tag: div, level: 10" node_number="285"> <div class="valid" valid="valid" title="valid: True, node: 286, tag: div, level: 11" node_number="286"> <div class="valid" valid="valid" title="valid: True, node: 287, tag: div, level: 12" node_number="287"> <div class="valid" valid="valid" title="valid: True, node: 288, tag: div, level: 13" node_number="288"> <a class="valid" valid="valid" title="valid: True, node: 289, tag: a, level: 14" node_number="289"> <i title="valid: False, node: 290, tag: i, level: 15" node_number="290">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 291, tag: div, level: 14" node_number="291"> Supplementary material: Supplementary File 1 (ZIP, 329 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 292, tag: div, level: 13" node_number="292"> <a class="valid" valid="valid" title="valid: True, node: 293, tag: a, level: 14" node_number="293"> <i title="valid: False, node: 294, tag: i, level: 15" node_number="294">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 295, tag: div, level: 13" node_number="295"> <a class="valid" valid="valid" title="valid: True, node: 296, tag: a, level: 14" node_number="296"> <i title="valid: False, node: 297, tag: i, level: 15" node_number="297">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 298, tag: div, level: 14" node_number="298"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 299, tag: div, level: 13" node_number="299">Open AccessArticle</div> Impact and Sustainability of Antibiotic Stewardship on Antibiotic Prescribing in Visceral Surgery <div class="valid" valid="valid" title="valid: True, node: 300, tag: div, level: 13" node_number="300"> by <span class="valid" valid="valid" title="valid: True, node: 301, tag: span, level: 14" node_number="301"><div title="valid: False, node: 302, tag: div, level: 15" node_number="302">Magdalena Monika Gruber</div>, </span><span class="valid" valid="valid" title="valid: True, node: 303, tag: span, level: 14" node_number="303"><div title="valid: False, node: 304, tag: div, level: 15" node_number="304">Alexandra Weber</div>, </span><span class="valid" valid="valid" title="valid: True, node: 305, tag: span, level: 14" node_number="305"><div title="valid: False, node: 306, tag: div, level: 15" node_number="306">Jette Jung</div>, </span><span class="valid" valid="valid" title="valid: True, node: 307, tag: span, level: 14" node_number="307"><div title="valid: False, node: 308, tag: div, level: 15" node_number="308">Jens Werner</div> and </span><span class="valid" valid="valid" title="valid: True, node: 309, tag: span, level: 14" node_number="309"><div title="valid: False, node: 310, tag: div, level: 15" node_number="310">Rika Draenert</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 311, tag: div, level: 13" node_number="311"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 312, tag: b, level: 14" node_number="312">2021</b>, 10(12), 1518; https://doi.org/10.3390/antibiotics10121518 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 313, tag: div, level: 13" node_number="313"> Abstract <div class="valid" valid="valid" title="valid: True, node: 314, tag: div, level: 14" node_number="314"> Background: Antibiotic stewardship (AS) ward rounds are a core element in clinical care for surgical patients. Therefore, we aimed to analyze the impact of surgical AS ward rounds on antibiotic prescribing, and the sustainability of the effect after the AS interventions are no [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 315, tag: div, level: 14" node_number="315"> Background: Antibiotic stewardship (AS) ward rounds are a core element in clinical care for surgical patients. Therefore, we aimed to analyze the impact of surgical AS ward rounds on antibiotic prescribing, and the sustainability of the effect after the AS interventions are no longer provided. Methods: On four wards of the department of visceral surgery, we conducted two independent retrospective prescribing analyses (P1, P2) over three months each. During the study periods, the level of AS intervention differed for two of the four wards (ward rounds/no ward rounds). Results: AS ward rounds were associated with a decrease in overall antibiotic consumption (91.1 days of therapy (DOT)/100 patient days (PD) (P1), 70.4 DOT/100PD (P2)), and improved de-escalation rates of antibiotic therapy (W1/2: 25.7% (P1), 40.0% (P2), <i title="valid: False, node: 316, tag: i, level: 15" node_number="316">p</i> = 0.030; W3: 15.4 (P1), 24.2 (P2), <i title="valid: False, node: 317, tag: i, level: 15" node_number="317">p</i> = 0.081). On the ward where AS measures were no longer provided, overall antibiotic usage remained stable (71.3 DOT/100PD (P1), 74.4 DOT/100PD (P2)), showing the sustainability of AS measures. However, the application of last-resort compounds increased from 6.4 DOT/100PD to 12.1 DOT/100PD (oxazolidinones) and from 10.8 DOT/100PD to 13.2 DOT/100PD (carbapenems). Conclusions: Antibiotic consumption can be reduced without negatively affecting patient outcomes. However, achieving lasting positive changes in antibiotic prescribing habits remains a challenge. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 318, tag: div, level: 13" node_number="318"> (This article belongs to the Special Issue The Optimization of Antimicrobial Prescribing and Stewardship) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 319, tag: div, level: 13" node_number="319"><div class="valid" valid="valid" title="valid: True, node: 320, tag: div, level: 14" node_number="320"><div title="valid: False, node: 321, tag: div, level: 15" node_number="321"><p title="valid: False, node: 322, tag: p, level: 16" node_number="322">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 323, tag: div, level: 10" node_number="323"> <div class="valid" valid="valid" title="valid: True, node: 324, tag: div, level: 11" node_number="324"> <div class="valid" valid="valid" title="valid: True, node: 325, tag: div, level: 12" node_number="325"> <div class="valid" valid="valid" title="valid: True, node: 326, tag: div, level: 13" node_number="326"> <a class="valid" valid="valid" title="valid: True, node: 327, tag: a, level: 14" node_number="327"> <i title="valid: False, node: 328, tag: i, level: 15" node_number="328">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 329, tag: div, level: 14" node_number="329"> Supplementary material: Supplementary File 1 (ZIP, 918 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 330, tag: div, level: 13" node_number="330"> <a class="valid" valid="valid" title="valid: True, node: 331, tag: a, level: 14" node_number="331"> <i title="valid: False, node: 332, tag: i, level: 15" node_number="332">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 333, tag: div, level: 13" node_number="333"> <a class="valid" valid="valid" title="valid: True, node: 334, tag: a, level: 14" node_number="334"> <i title="valid: False, node: 335, tag: i, level: 15" node_number="335">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 336, tag: div, level: 14" node_number="336"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 337, tag: div, level: 13" node_number="337">Open AccessArticle</div> Essential Oil Blends: The Potential of Combined Use for Respiratory Tract Infections <div class="valid" valid="valid" title="valid: True, node: 338, tag: div, level: 13" node_number="338"> by <span class="valid" valid="valid" title="valid: True, node: 339, tag: span, level: 14" node_number="339"><div title="valid: False, node: 340, tag: div, level: 15" node_number="340">Stephanie Leigh-de Rapper</div>, </span><span class="valid" valid="valid" title="valid: True, node: 341, tag: span, level: 14" node_number="341"><div title="valid: False, node: 342, tag: div, level: 15" node_number="342">Alvaro Viljoen</div> and </span><span class="valid" valid="valid" title="valid: True, node: 343, tag: span, level: 14" node_number="343"><div title="valid: False, node: 344, tag: div, level: 15" node_number="344">Sandy van Vuuren</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 345, tag: div, level: 13" node_number="345"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 346, tag: b, level: 14" node_number="346">2021</b>, 10(12), 1517; https://doi.org/10.3390/antibiotics10121517 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 347, tag: div, level: 13" node_number="347"> Abstract <div class="valid" valid="valid" title="valid: True, node: 348, tag: div, level: 14" node_number="348"> This study investigated the potential efficacy of 369 commercial essential oil combinations for antimicrobial, anti-toxic and anti-inflammatory activity with the aim of identifying synergy among essential oils commonly used in combination by aromatherapists for respiratory purposes. Essential oil combinations were assessed for their [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 349, tag: div, level: 14" node_number="349"> This study investigated the potential efficacy of 369 commercial essential oil combinations for antimicrobial, anti-toxic and anti-inflammatory activity with the aim of identifying synergy among essential oils commonly used in combination by aromatherapists for respiratory purposes. Essential oil combinations were assessed for their antimicrobial activities using a panel of Gram-positive, Gram-negative, and yeast strains associated with respiratory tract infections. The antimicrobial activity was measured by determining the minimal inhibitory concentration (MIC) of microbial growth. The fractional inhibitory concentration index (&#931;FIC) was calculated to determine the antimicrobial interactions between the essential oils in the combination. The toxicity of the essential oil combinations was tested <i title="valid: False, node: 350, tag: i, level: 15" node_number="350">in vitro</i> using the brine shrimp lethality assay, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay on RAW 264.7 mouse macrophage cells and A549 lung cancer cell lines. In addition, an inflammatory response was evaluated measuring nitric oxide production. The essential oils, when in combination, demonstrated an increased antimicrobial effect, a reduction in toxicity and provided improved anti-inflammatory outcomes. Five distinct combinations [<i title="valid: False, node: 351, tag: i, level: 15" node_number="351">Cupressus</i> <i title="valid: False, node: 352, tag: i, level: 15" node_number="352">sempervirens</i> (cypress) in combination with <i title="valid: False, node: 353, tag: i, level: 15" node_number="353">Melaleuca</i> <i title="valid: False, node: 354, tag: i, level: 15" node_number="354">alternifolia</i> (tea tree), <i title="valid: False, node: 355, tag: i, level: 15" node_number="355">Hyssopus</i> <i title="valid: False, node: 356, tag: i, level: 15" node_number="356">officinalis</i> (hyssop) in combination with <i title="valid: False, node: 357, tag: i, level: 15" node_number="357">Rosmarinus</i> <i title="valid: False, node: 358, tag: i, level: 15" node_number="358">officinalis</i> (rosemary), <i title="valid: False, node: 359, tag: i, level: 15" node_number="359">Origanum</i> <i title="valid: False, node: 360, tag: i, level: 15" node_number="360">marjorana</i> (marjoram) in combination with <i title="valid: False, node: 361, tag: i, level: 15" node_number="361">M.</i> <i title="valid: False, node: 362, tag: i, level: 15" node_number="362">alternifolia</i>, <i title="valid: False, node: 363, tag: i, level: 15" node_number="363">Myrtus</i> <i title="valid: False, node: 364, tag: i, level: 15" node_number="364">communis</i> (myrtle) in combination with <i title="valid: False, node: 365, tag: i, level: 15" node_number="365">M.</i> <i title="valid: False, node: 366, tag: i, level: 15" node_number="366">alternifolia</i> and <i title="valid: False, node: 367, tag: i, level: 15" node_number="367">Origanum</i> <i title="valid: False, node: 368, tag: i, level: 15" node_number="368">vulgare</i> (origanum) in combination with <i title="valid: False, node: 369, tag: i, level: 15" node_number="369">M.</i> <i title="valid: False, node: 370, tag: i, level: 15" node_number="370">alternifolia</i>] were found to be the most promising, demonstrating antimicrobial activity, reduced cytotoxicity and improved anti-inflammatory effects. With the increased prevalence of respiratory tract infections and the growing antimicrobial resistance development associated with antimicrobial treatments, this study provides a promising complementary alternative for the appropriate use of a selection of essential oil combinations for use in the respiratory tract. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 371, tag: div, level: 13" node_number="371"> (This article belongs to the Special Issue 10th Anniversary of Antibiotics&#8212;Recent Advances in Plant-Derived Antibiotics) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 372, tag: div, level: 13" node_number="372"><div class="valid" valid="valid" title="valid: True, node: 373, tag: div, level: 14" node_number="373"><div title="valid: False, node: 374, tag: div, level: 15" node_number="374"><p title="valid: False, node: 375, tag: p, level: 16" node_number="375">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 376, tag: div, level: 10" node_number="376"> <div class="valid" valid="valid" title="valid: True, node: 377, tag: div, level: 11" node_number="377"> <div class="valid" valid="valid" title="valid: True, node: 378, tag: div, level: 12" node_number="378"> <div class="valid" valid="valid" title="valid: True, node: 379, tag: div, level: 13" node_number="379"> <a class="valid" valid="valid" title="valid: True, node: 380, tag: a, level: 14" node_number="380"> <i title="valid: False, node: 381, tag: i, level: 15" node_number="381">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 382, tag: div, level: 14" node_number="382"> Supplementary material: Supplementary File 1 (ZIP, 3176 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 383, tag: div, level: 13" node_number="383"> <a class="valid" valid="valid" title="valid: True, node: 384, tag: a, level: 14" node_number="384"> <i title="valid: False, node: 385, tag: i, level: 15" node_number="385">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 386, tag: div, level: 13" node_number="386"> <a class="valid" valid="valid" title="valid: True, node: 387, tag: a, level: 14" node_number="387"> <i title="valid: False, node: 388, tag: i, level: 15" node_number="388">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 389, tag: div, level: 14" node_number="389"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 390, tag: div, level: 13" node_number="390">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 391, tag: a, level: 13" node_number="391">Anti-Colonization Effect of Au Surfaces with Self-Assembled Molecular Monolayers Functionalized with Antimicrobial Peptides on <i class="valid" valid="valid" title="valid: True, node: 392, tag: i, level: 14" node_number="392">S. epidermidis</i></a> <div class="valid" valid="valid" title="valid: True, node: 393, tag: div, level: 13" node_number="393"> by <span class="valid" valid="valid" title="valid: True, node: 394, tag: span, level: 14" node_number="394"><div title="valid: False, node: 395, tag: div, level: 15" node_number="395">Eskil Andr&#233; Karlsen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 396, tag: span, level: 14" node_number="396"><div title="valid: False, node: 397, tag: div, level: 15" node_number="397">Wenche Stensen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 398, tag: span, level: 14" node_number="398"><div title="valid: False, node: 399, tag: div, level: 15" node_number="399">Eric Juskewitz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 400, tag: span, level: 14" node_number="400"><div title="valid: False, node: 401, tag: div, level: 15" node_number="401">Johan Svenson</div>, </span><span class="valid" valid="valid" title="valid: True, node: 402, tag: span, level: 14" node_number="402"><div title="valid: False, node: 403, tag: div, level: 15" node_number="403">Mattias Berglin</div> and </span><span class="valid" valid="valid" title="valid: True, node: 404, tag: span, level: 14" node_number="404"><div title="valid: False, node: 405, tag: div, level: 15" node_number="405">John Sigurd Mj&#248;en Svendsen</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 406, tag: div, level: 13" node_number="406"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 407, tag: b, level: 14" node_number="407">2021</b>, 10(12), 1516; https://doi.org/10.3390/antibiotics10121516 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 408, tag: div, level: 13" node_number="408"> Abstract <div class="valid" valid="valid" title="valid: True, node: 409, tag: div, level: 14" node_number="409"> Medical devices with an effective anti-colonization surface are important tools for combatting healthcare-associated infections. Here, we investigated the anti-colonization efficacy of antimicrobial peptides covalently attached to a gold model surface. The gold surface was modified by a self-assembled polyethylene glycol monolayer with an [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 410, tag: div, level: 14" node_number="410"> Medical devices with an effective anti-colonization surface are important tools for combatting healthcare-associated infections. Here, we investigated the anti-colonization efficacy of antimicrobial peptides covalently attached to a gold model surface. The gold surface was modified by a self-assembled polyethylene glycol monolayer with an acetylene terminus. The peptides were covalently connected to the surface through a copper-catalyzed [3 + 2] azide-acetylene coupling (CuAAC). The anti-colonization efficacy of the surfaces varied as a function of the antimicrobial activity of the peptides, and very effective surfaces could be prepared with a 6 log unit reduction in bacterial colonization. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 411, tag: div, level: 13" node_number="411"> (This article belongs to the Special Issue Antimicrobial Materials and Surface) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 412, tag: div, level: 13" node_number="412"><div class="valid" valid="valid" title="valid: True, node: 413, tag: div, level: 14" node_number="413"><div title="valid: False, node: 414, tag: div, level: 15" node_number="414"><p title="valid: False, node: 415, tag: p, level: 16" node_number="415">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 416, tag: div, level: 10" node_number="416"> <div class="valid" valid="valid" title="valid: True, node: 417, tag: div, level: 11" node_number="417"> <div class="valid" valid="valid" title="valid: True, node: 418, tag: div, level: 12" node_number="418"> <div class="valid" valid="valid" title="valid: True, node: 419, tag: div, level: 13" node_number="419"> <a class="valid" valid="valid" title="valid: True, node: 420, tag: a, level: 14" node_number="420"> <i title="valid: False, node: 421, tag: i, level: 15" node_number="421">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 422, tag: div, level: 13" node_number="422"> <a class="valid" valid="valid" title="valid: True, node: 423, tag: a, level: 14" node_number="423"> <i title="valid: False, node: 424, tag: i, level: 15" node_number="424">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 425, tag: div, level: 14" node_number="425"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 426, tag: div, level: 13" node_number="426">Open AccessReview</div> Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model <div class="valid" valid="valid" title="valid: True, node: 427, tag: div, level: 13" node_number="427"> by <span class="valid" valid="valid" title="valid: True, node: 428, tag: span, level: 14" node_number="428"><div title="valid: False, node: 429, tag: div, level: 15" node_number="429">Arundhati Maitra</div>, </span><span class="valid" valid="valid" title="valid: True, node: 430, tag: span, level: 14" node_number="430"><div title="valid: False, node: 431, tag: div, level: 15" node_number="431">Priya Solanki</div>, </span><span class="valid" valid="valid" title="valid: True, node: 432, tag: span, level: 14" node_number="432"><div title="valid: False, node: 433, tag: div, level: 15" node_number="433">Zahra Sadouki</div>, </span><span class="valid" valid="valid" title="valid: True, node: 434, tag: span, level: 14" node_number="434"><div title="valid: False, node: 435, tag: div, level: 15" node_number="435">Timothy D. McHugh</div> and </span><span class="valid" valid="valid" title="valid: True, node: 436, tag: span, level: 14" node_number="436"><div title="valid: False, node: 437, tag: div, level: 15" node_number="437">Frank Kloprogge</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 438, tag: div, level: 13" node_number="438"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 439, tag: b, level: 14" node_number="439">2021</b>, 10(12), 1515; https://doi.org/10.3390/antibiotics10121515 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 440, tag: div, level: 13" node_number="440"> Abstract <div class="valid" valid="valid" title="valid: True, node: 441, tag: div, level: 14" node_number="441"> Mycobacterial infections are difficult to treat, requiring a combination of drugs and lengthy treatment times, thereby presenting a substantial burden to both the patient and health services worldwide. The limited treatment options available are under threat due to the emergence of antibiotic resistance [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 442, tag: div, level: 14" node_number="442"> Mycobacterial infections are difficult to treat, requiring a combination of drugs and lengthy treatment times, thereby presenting a substantial burden to both the patient and health services worldwide. The limited treatment options available are under threat due to the emergence of antibiotic resistance in the pathogen, hence necessitating the development of new treatment regimens. Drug development processes are lengthy, resource intensive, and high-risk, which have contributed to market failure as demonstrated by pharmaceutical companies limiting their antimicrobial drug discovery programmes. Pre-clinical protocols evaluating treatment regimens that can mimic in vivo PK/PD attributes can underpin the drug development process. The hollow fibre infection model (HFIM) allows for the pathogen to be exposed to a single or a combination of agents at concentrations achieved in vivo&#8211;in plasma or at infection sites. Samples taken from the HFIM, depending on the analyses performed, provide information on the rate of bacterial killing and the emergence of resistance. Thereby, the HFIM is an effective means to investigate the efficacy of a drug combination. Although applicable to a wide variety of infections, the complexity of anti-mycobacterial drug discovery makes the information available from the HFIM invaluable as explored in this review. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 443, tag: div, level: 13" node_number="443"> (This article belongs to the Special Issue Tackling Antimicrobial Resistance in Global Infectious Bacterial Pathogens) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 444, tag: div, level: 13" node_number="444"><div class="valid" valid="valid" title="valid: True, node: 445, tag: div, level: 14" node_number="445"><div title="valid: False, node: 446, tag: div, level: 15" node_number="446"><p title="valid: False, node: 447, tag: p, level: 16" node_number="447">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 448, tag: div, level: 10" node_number="448"> <div class="valid" valid="valid" title="valid: True, node: 449, tag: div, level: 11" node_number="449"> <div class="valid" valid="valid" title="valid: True, node: 450, tag: div, level: 12" node_number="450"> <div class="valid" valid="valid" title="valid: True, node: 451, tag: div, level: 13" node_number="451"> <a class="valid" valid="valid" title="valid: True, node: 452, tag: a, level: 14" node_number="452"> <i title="valid: False, node: 453, tag: i, level: 15" node_number="453">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 454, tag: div, level: 14" node_number="454"> Supplementary material: Supplementary File 1 (ZIP, 74 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 455, tag: div, level: 13" node_number="455"> <a class="valid" valid="valid" title="valid: True, node: 456, tag: a, level: 14" node_number="456"> <i title="valid: False, node: 457, tag: i, level: 15" node_number="457">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 458, tag: div, level: 13" node_number="458"> <a class="valid" valid="valid" title="valid: True, node: 459, tag: a, level: 14" node_number="459"> <i title="valid: False, node: 460, tag: i, level: 15" node_number="460">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 461, tag: div, level: 14" node_number="461"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 462, tag: div, level: 13" node_number="462">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 463, tag: a, level: 13" node_number="463">Chemical, Cytotoxic, and Anti-Inflammatory Assessment of Honey Bee Venom from <i class="valid" valid="valid" title="valid: True, node: 464, tag: i, level: 14" node_number="464">Apis mellifera intermissa</i></a> <div class="valid" valid="valid" title="valid: True, node: 465, tag: div, level: 13" node_number="465"> by <span class="valid" valid="valid" title="valid: True, node: 466, tag: span, level: 14" node_number="466"><div title="valid: False, node: 467, tag: div, level: 15" node_number="467">Iouraouine El Mehdi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 468, tag: span, level: 14" node_number="468"><div title="valid: False, node: 469, tag: div, level: 15" node_number="469">Soraia I. Falc&#227;o</div>, </span><span class="valid" valid="valid" title="valid: True, node: 470, tag: span, level: 14" node_number="470"><div title="valid: False, node: 471, tag: div, level: 15" node_number="471">Mustapha Harandou</div>, </span><span class="valid" valid="valid" title="valid: True, node: 472, tag: span, level: 14" node_number="472"><div title="valid: False, node: 473, tag: div, level: 15" node_number="473">Sa&#239;d Boujraf</div>, </span><span class="valid" valid="valid" title="valid: True, node: 474, tag: span, level: 14" node_number="474"><div title="valid: False, node: 475, tag: div, level: 15" node_number="475">Ricardo C. Calhelha</div>, </span><span class="valid" valid="valid" title="valid: True, node: 476, tag: span, level: 14" node_number="476"><div title="valid: False, node: 477, tag: div, level: 15" node_number="477">Isabel C. F. R. Ferreira</div>, </span><span class="valid" valid="valid" title="valid: True, node: 478, tag: span, level: 14" node_number="478"><div title="valid: False, node: 479, tag: div, level: 15" node_number="479">Of&#233;lia Anjos</div>, </span><span class="valid" valid="valid" title="valid: True, node: 480, tag: span, level: 14" node_number="480"><div title="valid: False, node: 481, tag: div, level: 15" node_number="481">Maria G. Campos</div> and </span><span class="valid" valid="valid" title="valid: True, node: 482, tag: span, level: 14" node_number="482"><div title="valid: False, node: 483, tag: div, level: 15" node_number="483">Miguel Vilas-Boas</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 484, tag: div, level: 13" node_number="484"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 485, tag: b, level: 14" node_number="485">2021</b>, 10(12), 1514; https://doi.org/10.3390/antibiotics10121514 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 486, tag: div, level: 13" node_number="486"> Abstract <div class="valid" valid="valid" title="valid: True, node: 487, tag: div, level: 14" node_number="487"> The venom from <i title="valid: False, node: 488, tag: i, level: 15" node_number="488">Apis mellifera intermissa</i>, the main honey bee prevailing in Morocco, has been scarcely studied, despite its known potential for pharmacological applications. In the present work, we investigated the composition, the anti-inflammatory activity, and the venom&#8217;s cytotoxic properties from fifteen [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 489, tag: div, level: 14" node_number="489"> The venom from <i title="valid: False, node: 490, tag: i, level: 15" node_number="490">Apis mellifera intermissa</i>, the main honey bee prevailing in Morocco, has been scarcely studied, despite its known potential for pharmacological applications. In the present work, we investigated the composition, the anti-inflammatory activity, and the venom&#8217;s cytotoxic properties from fifteen honey bee venom (HBV) samples collected in three regions: northeast, central, and southern Morocco. The chemical assessment of honey bee venom was performed using LC-DAD/ESI/MS<sup title="valid: False, node: 491, tag: sup, level: 15" node_number="491">n</sup>, NIR spectroscopy and AAS spectroscopy. The antiproliferative effect was evaluated using human tumor cell lines, including breast adenocarcinoma, non-small cell lung carcinoma, cervical carcinoma, hepatocellular carcinoma, and malignant melanoma. Likewise, we assessed the anti-inflammatory activity using the murine macrophage cell line. The study provides information on the honey bee venom subspecies&#8217; main components, such as melittin, apamin, and phospholipase A2, with compositional variation depending on the region of collection. Contents of toxic elements such as cadmium, chromium, and plumb were detected at a concentration below 5 ppm, which can be regarded as safe for pharmaceutical use. The data presented contribute to the first study in HBV from <i title="valid: False, node: 492, tag: i, level: 15" node_number="492">Apis mellifera intermissa</i> and highlight the remarkable antiproliferative and anti-inflammatory effects of HBV, suggesting it to be a candidate natural medicine to explore. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 493, tag: div, level: 13" node_number="493"> (This article belongs to the Special Issue Honey Bee Products as an Alternative or Complement to Classical Antibiotics &#8211; 2nd Edition) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 494, tag: div, level: 13" node_number="494"><div class="valid" valid="valid" title="valid: True, node: 495, tag: div, level: 14" node_number="495"><div title="valid: False, node: 496, tag: div, level: 15" node_number="496"><p title="valid: False, node: 497, tag: p, level: 16" node_number="497">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 498, tag: div, level: 10" node_number="498"> <div class="valid" valid="valid" title="valid: True, node: 499, tag: div, level: 11" node_number="499"> <div class="valid" valid="valid" title="valid: True, node: 500, tag: div, level: 12" node_number="500"> <div class="valid" valid="valid" title="valid: True, node: 501, tag: div, level: 13" node_number="501"> <a class="valid" valid="valid" title="valid: True, node: 502, tag: a, level: 14" node_number="502"> <i title="valid: False, node: 503, tag: i, level: 15" node_number="503">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 504, tag: div, level: 13" node_number="504"> <a class="valid" valid="valid" title="valid: True, node: 505, tag: a, level: 14" node_number="505"> <i title="valid: False, node: 506, tag: i, level: 15" node_number="506">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 507, tag: div, level: 14" node_number="507"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 508, tag: div, level: 13" node_number="508">Open AccessArticle</div> Bacterial Epidemiology of Surgical Site Infections after Open Fractures of the Lower Limb: A Retrospective Cohort Study <div class="valid" valid="valid" title="valid: True, node: 509, tag: div, level: 13" node_number="509"> by <span class="valid" valid="valid" title="valid: True, node: 510, tag: span, level: 14" node_number="510"><div title="valid: False, node: 511, tag: div, level: 15" node_number="511">Tracie Joyner Youbong</div>, </span><span class="valid" valid="valid" title="valid: True, node: 512, tag: span, level: 14" node_number="512"><div title="valid: False, node: 513, tag: div, level: 15" node_number="513">Astrid De Pontfarcy</div>, </span><span class="valid" valid="valid" title="valid: True, node: 514, tag: span, level: 14" node_number="514"><div title="valid: False, node: 515, tag: div, level: 15" node_number="515">Maxence Rouyer</div>, </span><span class="valid" valid="valid" title="valid: True, node: 516, tag: span, level: 14" node_number="516"><div title="valid: False, node: 517, tag: div, level: 15" node_number="517">Alessio Strazzula</div>, </span><span class="valid" valid="valid" title="valid: True, node: 518, tag: span, level: 14" node_number="518"><div title="valid: False, node: 519, tag: div, level: 15" node_number="519">Catherine Chakvetadze</div>, </span><span class="valid" valid="valid" title="valid: True, node: 520, tag: span, level: 14" node_number="520"><div title="valid: False, node: 521, tag: div, level: 15" node_number="521">Clara Flateau</div>, </span><span class="valid" valid="valid" title="valid: True, node: 522, tag: span, level: 14" node_number="522"><div title="valid: False, node: 523, tag: div, level: 15" node_number="523">Samir Sayegh</div>, </span><span class="valid" valid="valid" title="valid: True, node: 524, tag: span, level: 14" node_number="524"><div title="valid: False, node: 525, tag: div, level: 15" node_number="525">Coralie Noel</div>, </span><span class="valid" valid="valid" title="valid: True, node: 526, tag: span, level: 14" node_number="526"><div title="valid: False, node: 527, tag: div, level: 15" node_number="527">Aur&#233;lia Pitsch</div>, </span><span class="valid" valid="valid" title="valid: True, node: 528, tag: span, level: 14" node_number="528"><div title="valid: False, node: 529, tag: div, level: 15" node_number="529">Abdelmalek Abbadi</div> and </span><span class="valid" valid="valid" title="valid: True, node: 530, tag: span, level: 14" node_number="530"><div title="valid: False, node: 531, tag: div, level: 15" node_number="531">Sylvain Diamantis</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 532, tag: div, level: 13" node_number="532"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 533, tag: b, level: 14" node_number="533">2021</b>, 10(12), 1513; https://doi.org/10.3390/antibiotics10121513 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 534, tag: div, level: 13" node_number="534"> Abstract <div class="valid" valid="valid" title="valid: True, node: 535, tag: div, level: 14" node_number="535"> Open lower limb fractures are common injuries, and the occurrence of infectious complications after open fractures is a usual problem. The rate of surgical site infections (SSIs) and the nature and resistance of the germs responsible for SSIs remain poorly described. Our aim [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 536, tag: div, level: 14" node_number="536"> Open lower limb fractures are common injuries, and the occurrence of infectious complications after open fractures is a usual problem. The rate of surgical site infections (SSIs) and the nature and resistance of the germs responsible for SSIs remain poorly described. Our aim was to describe the bacterial epidemiology of SSIs after surgical management of an open lower limb fracture. We conducted a retrospective monocentric cohort study from 1 January 2012 to 31 December 2020 based on the analysis of inpatient records in a non-university hospital of Ile de France region. All patients who underwent surgery for an open lower limb fracture were included. A total of 149 patients were included. In our population, 19 (12.7%) patients developed an SSI. Of these 19 patients, the sample was polymicrobial in 9 (47.4%) patients. In 9 (45%) cases, the samples identified a group 3 enterobacteria, Enterobacter cloacae being the main one in 7 (36.9%) cases. Staphylococci were identified in 11 patients, with Staphylococcus aureus in 9 (47.4%). All Staphylococcus aureus were susceptible to methicillin, and all enterobacteria were susceptible to C3G. Among all SSI, 10 (58.8%) contained at least one germ resistant to amoxicillin/clavulanic acid (AMC). The SSIs rate was 12.7%. The main pathogens identified were Enterobacter cloacae and Staphylococcus aureus. The presence of early SSI caused by group 3 Enterobacteriaceae renders current antibiotic prophylaxis protocols inadequate with AMC in half the cases. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 537, tag: div, level: 13" node_number="537"> (This article belongs to the Special Issue Antibiotic Prophylaxis for Surgical Site Infection in General Surgery) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 538, tag: div, level: 13" node_number="538"><div class="valid" valid="valid" title="valid: True, node: 539, tag: div, level: 14" node_number="539"><div title="valid: False, node: 540, tag: div, level: 15" node_number="540"><p title="valid: False, node: 541, tag: p, level: 16" node_number="541">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 542, tag: div, level: 10" node_number="542"> <div class="valid" valid="valid" title="valid: True, node: 543, tag: div, level: 11" node_number="543"> <div class="valid" valid="valid" title="valid: True, node: 544, tag: div, level: 12" node_number="544"> <div class="valid" valid="valid" title="valid: True, node: 545, tag: div, level: 13" node_number="545"> <a class="valid" valid="valid" title="valid: True, node: 546, tag: a, level: 14" node_number="546"> <i title="valid: False, node: 547, tag: i, level: 15" node_number="547">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 548, tag: div, level: 13" node_number="548"> <a class="valid" valid="valid" title="valid: True, node: 549, tag: a, level: 14" node_number="549"> <i title="valid: False, node: 550, tag: i, level: 15" node_number="550">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 551, tag: div, level: 14" node_number="551"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 552, tag: div, level: 13" node_number="552">Open AccessArticle</div> Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from The Netherlands Pharmacovigilance Centre <div class="valid" valid="valid" title="valid: True, node: 553, tag: div, level: 13" node_number="553"> by <span class="valid" valid="valid" title="valid: True, node: 554, tag: span, level: 14" node_number="554"><div title="valid: False, node: 555, tag: div, level: 15" node_number="555">Jean Marie Vianney Habarugira</div>, </span><span class="valid" valid="valid" title="valid: True, node: 556, tag: span, level: 14" node_number="556"><div title="valid: False, node: 557, tag: div, level: 15" node_number="557">Linda H&#228;rmark</div> and </span><span class="valid" valid="valid" title="valid: True, node: 558, tag: span, level: 14" node_number="558"><div title="valid: False, node: 559, tag: div, level: 15" node_number="559">Albert Figueras</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 560, tag: div, level: 13" node_number="560"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 561, tag: b, level: 14" node_number="561">2021</b>, 10(12), 1512; https://doi.org/10.3390/antibiotics10121512 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 562, tag: div, level: 13" node_number="562"> Abstract <div class="valid" valid="valid" title="valid: True, node: 563, tag: div, level: 14" node_number="563"> (1) Background: Antimicrobial resistance (AMR) requires urgent multidisciplinary solutions, and pharmacovigilance has the potential to strengthen current antimicrobial stewardship strategies. This study aimed to characterize AMR-relevant adverse drug reaction (ADR) reports submitted to The Netherlands Pharmacovigilance Centre; (2) Methods: We carried out a [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 564, tag: div, level: 14" node_number="564"> (1) Background: Antimicrobial resistance (AMR) requires urgent multidisciplinary solutions, and pharmacovigilance has the potential to strengthen current antimicrobial stewardship strategies. This study aimed to characterize AMR-relevant adverse drug reaction (ADR) reports submitted to The Netherlands Pharmacovigilance Centre; (2) Methods: We carried out a descriptive analysis of ADR reports submitted to Lareb, coded with AMR-relevant MedDRA Preferred Terms (PTs); (3) Results: Between 1998 and January 2019, 252 AMR-relevant ADR reports were submitted to Lareb. The most frequent antibiotics were tobramycin (<i title="valid: False, node: 565, tag: i, level: 15" node_number="565">n</i> = 89; 35%), colistin (<i title="valid: False, node: 566, tag: i, level: 15" node_number="566">n</i> = 30; 11.9%), cipro-floxacin (<i title="valid: False, node: 567, tag: i, level: 15" node_number="567">n</i> = 16; 6.3%), doxycycline (<i title="valid: False, node: 568, tag: i, level: 15" node_number="568">n</i> = 14; 5.5%), and aztreonam (<i title="valid: False, node: 569, tag: i, level: 15" node_number="569">n</i> = 12; 4.8%). The PTs used included off label use (<i title="valid: False, node: 570, tag: i, level: 15" node_number="570">n</i> = 91; 36.1%), drug ineffective (<i title="valid: False, node: 571, tag: i, level: 15" node_number="571">n</i> = 71; 28.2%), product use in unapproved indication (<i title="valid: False, node: 572, tag: i, level: 15" node_number="572">n</i> = 28; 11.1%), pathogen resistance (<i title="valid: False, node: 573, tag: i, level: 15" node_number="573">n</i> = 14; 5.6%), and drug resistance (<i title="valid: False, node: 574, tag: i, level: 15" node_number="574">n</i> = 13; 5.2%). 54% of the reports were on Watch antibiotics and 19% were involved in the Reserve group. In the Watch group, &#8220;off label use&#8221; and &#8220;product use in unapproved indication&#8221; were the most frequent PTs and the majority of reports on Reserve antibiotics were coded as &#8220;Off label&#8221;. A sharp increase in the number of reports was observed in the three consecutive years with 21 in 2013, 54 in 2014, and 83 in 2015; (4) Conclusions: In addition to existing AMR monitoring strategies, pharmacovigilance databases can serve as a source of data on suspected resistance and inappropriate use. Future research should explore how these AMR-relevant MedDRA Terms are used in resource-limited settings with less capacity to generate laboratory-confirmed resistance data. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 575, tag: div, level: 13" node_number="575"> (This article belongs to the Special Issue 10th Anniversary of Antibiotics &#8212; Recent Advances in Rational Antimicrobial Use) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 576, tag: div, level: 13" node_number="576"><div class="valid" valid="valid" title="valid: True, node: 577, tag: div, level: 14" node_number="577"><div title="valid: False, node: 578, tag: div, level: 15" node_number="578"><p title="valid: False, node: 579, tag: p, level: 16" node_number="579">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 580, tag: div, level: 10" node_number="580"> <div class="valid" valid="valid" title="valid: True, node: 581, tag: div, level: 11" node_number="581"> <div class="valid" valid="valid" title="valid: True, node: 582, tag: div, level: 12" node_number="582"> <div class="valid" valid="valid" title="valid: True, node: 583, tag: div, level: 13" node_number="583"> <a class="valid" valid="valid" title="valid: True, node: 584, tag: a, level: 14" node_number="584"> <i title="valid: False, node: 585, tag: i, level: 15" node_number="585">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 586, tag: div, level: 14" node_number="586"> Supplementary material: Supplementary File 1 (ZIP, 119 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 587, tag: div, level: 13" node_number="587"> <a class="valid" valid="valid" title="valid: True, node: 588, tag: a, level: 14" node_number="588"> <i title="valid: False, node: 589, tag: i, level: 15" node_number="589">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 590, tag: div, level: 13" node_number="590"> <a class="valid" valid="valid" title="valid: True, node: 591, tag: a, level: 14" node_number="591"> <i title="valid: False, node: 592, tag: i, level: 15" node_number="592">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 593, tag: div, level: 14" node_number="593"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 594, tag: div, level: 13" node_number="594">Open AccessArticle</div> Real Life Clinical Impact of Antimicrobial Stewardship Actions on the Blood Culture Workflow from a Microbiology Laboratory <div class="valid" valid="valid" title="valid: True, node: 595, tag: div, level: 13" node_number="595"> by <span class="valid" valid="valid" title="valid: True, node: 596, tag: span, level: 14" node_number="596"><div title="valid: False, node: 597, tag: div, level: 15" node_number="597">Jose Maria L&#243;pez-Pintor</div>, </span><span class="valid" valid="valid" title="valid: True, node: 598, tag: span, level: 14" node_number="598"><div title="valid: False, node: 599, tag: div, level: 15" node_number="599">Javier S&#225;nchez-L&#243;pez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 600, tag: span, level: 14" node_number="600"><div title="valid: False, node: 601, tag: div, level: 15" node_number="601">Carolina Navarro-San Francisco</div>, </span><span class="valid" valid="valid" title="valid: True, node: 602, tag: span, level: 14" node_number="602"><div title="valid: False, node: 603, tag: div, level: 15" node_number="603">Ana Maria S&#225;nchez-D&#237;az</div>, </span><span class="valid" valid="valid" title="valid: True, node: 604, tag: span, level: 14" node_number="604"><div title="valid: False, node: 605, tag: div, level: 15" node_number="605">Elena Loza</div> and </span><span class="valid" valid="valid" title="valid: True, node: 606, tag: span, level: 14" node_number="606"><div title="valid: False, node: 607, tag: div, level: 15" node_number="607">Rafael Cant&#243;n</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 608, tag: div, level: 13" node_number="608"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 609, tag: b, level: 14" node_number="609">2021</b>, 10(12), 1511; https://doi.org/10.3390/antibiotics10121511 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 610, tag: div, level: 13" node_number="610"> Abstract <div class="valid" valid="valid" title="valid: True, node: 611, tag: div, level: 14" node_number="611"> Background: Accelerating the diagnosis of bacteremia is one of the biggest challenges in clinical microbiology departments. The fast establishment of a correct treatment is determinant on bacteremic patients&#8217; outcomes. Our objective was to evaluate the impact of antimicrobial therapy and clinical outcomes of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 612, tag: div, level: 14" node_number="612"> Background: Accelerating the diagnosis of bacteremia is one of the biggest challenges in clinical microbiology departments. The fast establishment of a correct treatment is determinant on bacteremic patients&#8217; outcomes. Our objective was to evaluate the impact of antimicrobial therapy and clinical outcomes of a rapid blood culture workflow protocol in positive blood cultures with Gram-negative bacilli (GNB). Methods: A quasi-experimental before&#8211;after study was performed with two groups: (i) control group (conventional work-protocol) and (ii) intervention group (rapid workflow-protocol: rapid identification by Matrix-Assisted Laser Desorption/Ionization-Time-Of-Flight (MALDI-TOF) and antimicrobial susceptibility testing (AST) from bacterial pellet without overnight incubation). Patients were divided into different categories according to the type of intervention over treatment. Outcomes were compared between both groups. Results: A total of 313 patients with GNB-bacteremia were included: 125 patients in the control group and 188 in the intervention. The time from positive blood culture to intervention on antibiotic treatment decreased from 2.0 days in the control group to 1.0 in the intervention group (<i title="valid: False, node: 613, tag: i, level: 15" node_number="613">p</i> &lt; 0.001). On the maintenance of correct empirical treatment, the control group reported 2.0 median days until the clinical decision, while in the intervention group was 1.0 (<i title="valid: False, node: 614, tag: i, level: 15" node_number="614">p</i> &lt; 0.001). In the case of treatment de-escalation, a significant difference between both groups (4.0 vs. 2.0, <i title="valid: False, node: 615, tag: i, level: 15" node_number="615">p</i> &lt; 0.001) was found. A decreasing trend on the change from inappropriate treatments to appropriate ones was observed: 3.5 vs. 1.5; <i title="valid: False, node: 616, tag: i, level: 15" node_number="616">p</i> = 0.12. No significant differences were found between both groups on 7-days mortality or on readmissions in the first 30-days. Conclusions: Routine implementation of a rapid workflow protocol anticipates the report of antimicrobial susceptibility testing results in patients with GNB-bacteremia, decreasing the time to effective and optimal antibiotic therapy. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 617, tag: div, level: 13" node_number="617"> (This article belongs to the Special Issue Key Collaborations between Antimicrobial Stewardship Clinical Microbiology &#8211; Focus on Diagnostic Stewardship) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 618, tag: div, level: 13" node_number="618"><div class="valid" valid="valid" title="valid: True, node: 619, tag: div, level: 14" node_number="619"><div title="valid: False, node: 620, tag: div, level: 15" node_number="620"><p title="valid: False, node: 621, tag: p, level: 16" node_number="621">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 622, tag: div, level: 10" node_number="622"> <div class="valid" valid="valid" title="valid: True, node: 623, tag: div, level: 11" node_number="623"> <div class="valid" valid="valid" title="valid: True, node: 624, tag: div, level: 12" node_number="624"> <div class="valid" valid="valid" title="valid: True, node: 625, tag: div, level: 13" node_number="625"> <a class="valid" valid="valid" title="valid: True, node: 626, tag: a, level: 14" node_number="626"> <i title="valid: False, node: 627, tag: i, level: 15" node_number="627">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 628, tag: div, level: 13" node_number="628"> <a class="valid" valid="valid" title="valid: True, node: 629, tag: a, level: 14" node_number="629"> <i title="valid: False, node: 630, tag: i, level: 15" node_number="630">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 631, tag: div, level: 14" node_number="631"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 632, tag: div, level: 13" node_number="632">Open AccessArticle</div> Comparison of Low-Versus High-Dose Steroids in the Clinical Outcome of Hospitalized COVID-19 Patients <div class="valid" valid="valid" title="valid: True, node: 633, tag: div, level: 13" node_number="633"> by <span class="valid" valid="valid" title="valid: True, node: 634, tag: span, level: 14" node_number="634"><div title="valid: False, node: 635, tag: div, level: 15" node_number="635">Zubia Jamil</div>, </span><span class="valid" valid="valid" title="valid: True, node: 636, tag: span, level: 14" node_number="636"><div title="valid: False, node: 637, tag: div, level: 15" node_number="637">Fahad N. Almajhdi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 638, tag: span, level: 14" node_number="638"><div title="valid: False, node: 639, tag: div, level: 15" node_number="639">Samreen Khalid</div>, </span><span class="valid" valid="valid" title="valid: True, node: 640, tag: span, level: 14" node_number="640"><div title="valid: False, node: 641, tag: div, level: 15" node_number="641">Muhammad Asghar</div>, </span><span class="valid" valid="valid" title="valid: True, node: 642, tag: span, level: 14" node_number="642"><div title="valid: False, node: 643, tag: div, level: 15" node_number="643">Jamal Ahmed</div> and </span><span class="valid" valid="valid" title="valid: True, node: 644, tag: span, level: 14" node_number="644"><div title="valid: False, node: 645, tag: div, level: 15" node_number="645">Yasir Waheed</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 646, tag: div, level: 13" node_number="646"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 647, tag: b, level: 14" node_number="647">2021</b>, 10(12), 1510; https://doi.org/10.3390/antibiotics10121510 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 648, tag: div, level: 13" node_number="648"> Abstract <div class="valid" valid="valid" title="valid: True, node: 649, tag: div, level: 14" node_number="649"> (1) Objectives: Patients with COVID-19 infection have been given various formulations and dosages of steroids over the last year and a half. This study aims to compare the effects of different formulations and doses of steroids on the 30 day in-hospital clinical outcome [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 650, tag: div, level: 14" node_number="650"> (1) Objectives: Patients with COVID-19 infection have been given various formulations and dosages of steroids over the last year and a half. This study aims to compare the effects of different formulations and doses of steroids on the 30 day in-hospital clinical outcome of patients with severe COVID-19 infection. (2) Material and Methods: An analysis of a retrospective cohort was carried out on patients with severe COVID-19 infection in a high-dependency unit (HDU) between February and July 2021. In total, 557 patients were included in this study. Patients who did not receive steroids (124) were excluded. Patients were divided into three groups based on dosages of steroids (Dexamethasone = 6 mg/day, Dexamethasone &gt; 6 mg/day, and Methylprednisolone = 500 mg/day), given for 10 days. First, clinical outcome was evaluated on the 10th day of steroid administration in relation to mode of oxygen delivery. Then, Kaplan&#8211;Meier analysis was employed to determine 30 day in-hospital survival in relation to the use of steroid. (3) Results: Three groups were statistically equal according to biochemical characteristics. After 10 days of Methylprednisolone = 500 mg/day vs. Dexamethasone = 6 mg/day, 10.9% vs. 6.2% of patients required invasive ventilation (<i title="valid: False, node: 651, tag: i, level: 15" node_number="651">p</i> = 0.01). The 30 day in-hospital mortality was lowest, 3%, in individuals receiving Dexamethasone = 6 mg/day, compared to 3.9% in individuals receiving Dexamethasone &gt; 6 mg/day and 9.9% in individuals receiving Methylprednisolone = 500 mg/day, respectively. The median elapsed time was longer than 28 days between admission and outcome for Dexamethasone = 6 mg/day, compared to 18 days for Dexamethasone &gt; 6 mg/day and 17 days for Methylprednisolone = 500 mg/day (<i title="valid: False, node: 652, tag: i, level: 15" node_number="652">p</i> = &lt; 0.0001). Dexamethasone = 6 mg/day was found to be a positive predictor of clinical outcome in COVID-19 patients on regression analysis. (4) Conclusions: Low-dose Dexamethasone (6 mg/day) is more effective than high-dose Dexamethasone and Methylprednisolone in improving the survival outcome of severe COVID-19 cases. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 653, tag: div, level: 13" node_number="653"> (This article belongs to the Special Issue Antibiotics and Therapeutic Agent Prescription in COVID-19 Management) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 654, tag: div, level: 13" node_number="654"><div class="valid" valid="valid" title="valid: True, node: 655, tag: div, level: 14" node_number="655"><div title="valid: False, node: 656, tag: div, level: 15" node_number="656"><p title="valid: False, node: 657, tag: p, level: 16" node_number="657">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 658, tag: div, level: 10" node_number="658"> <div class="valid" valid="valid" title="valid: True, node: 659, tag: div, level: 11" node_number="659"> <div class="valid" valid="valid" title="valid: True, node: 660, tag: div, level: 12" node_number="660"> <div class="valid" valid="valid" title="valid: True, node: 661, tag: div, level: 13" node_number="661"> <a class="valid" valid="valid" title="valid: True, node: 662, tag: a, level: 14" node_number="662"> <i title="valid: False, node: 663, tag: i, level: 15" node_number="663">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 664, tag: div, level: 13" node_number="664"> <a class="valid" valid="valid" title="valid: True, node: 665, tag: a, level: 14" node_number="665"> <i title="valid: False, node: 666, tag: i, level: 15" node_number="666">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 667, tag: div, level: 14" node_number="667"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 668, tag: div, level: 13" node_number="668">Open AccessArticle</div> The Effect of Pharmacist-Led Intervention on Surgical Antibacterial Prophylaxis (SAP) at an Orthopedic Unit <div class="valid" valid="valid" title="valid: True, node: 669, tag: div, level: 13" node_number="669"> by <span class="valid" valid="valid" title="valid: True, node: 670, tag: span, level: 14" node_number="670"><div title="valid: False, node: 671, tag: div, level: 15" node_number="671">Adina F&#233;s&#252;s</div>, </span><span class="valid" valid="valid" title="valid: True, node: 672, tag: span, level: 14" node_number="672"><div title="valid: False, node: 673, tag: div, level: 15" node_number="673">Ria Benk&#337;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 674, tag: span, level: 14" node_number="674"><div title="valid: False, node: 675, tag: div, level: 15" node_number="675">M&#225;ria Matuz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 676, tag: span, level: 14" node_number="676"><div title="valid: False, node: 677, tag: div, level: 15" node_number="677">Orsolya Kungler-Gor&#225;cz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 678, tag: span, level: 14" node_number="678"><div title="valid: False, node: 679, tag: div, level: 15" node_number="679">M&#225;rton &#193;. F&#233;s&#252;s</div>, </span><span class="valid" valid="valid" title="valid: True, node: 680, tag: span, level: 14" node_number="680"><div title="valid: False, node: 681, tag: div, level: 15" node_number="681">Tam&#225;s Bazs&#243;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 682, tag: span, level: 14" node_number="682"><div title="valid: False, node: 683, tag: div, level: 15" node_number="683">Zolt&#225;n Csern&#225;tony</div> and </span><span class="valid" valid="valid" title="valid: True, node: 684, tag: span, level: 14" node_number="684"><div title="valid: False, node: 685, tag: div, level: 15" node_number="685">G&#225;bor Kardos</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 686, tag: div, level: 13" node_number="686"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 687, tag: b, level: 14" node_number="687">2021</b>, 10(12), 1509; https://doi.org/10.3390/antibiotics10121509 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 688, tag: div, level: 13" node_number="688"> Abstract <div class="valid" valid="valid" title="valid: True, node: 689, tag: div, level: 14" node_number="689"> Perioperative antibiotic use is a common reason for antibiotic misuse. Evidence suggests that adherence to SAP guidelines may improve outcomes. The purpose of this study was to analyze the impact of pharmacist-led antibiotic stewardship interventions on SAP guideline compliance. The study was conducted [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 690, tag: div, level: 14" node_number="690"> Perioperative antibiotic use is a common reason for antibiotic misuse. Evidence suggests that adherence to SAP guidelines may improve outcomes. The purpose of this study was to analyze the impact of pharmacist-led antibiotic stewardship interventions on SAP guideline compliance. The study was conducted at an Orthopedic Department of a tertiary care medical center. SAP compliance and antibiotic exposure in the pre-intervention and intervention period was compared using chi-square, Fisher exact, and Mann-Whitney tests, as appropriate. Prophylactic antibiotic use in orthopedic joint arthroplasties (overall guideline adherence: agent, dose, frequency, duration), clinical outcomes (length of stay-LOS, number of surgical site infections-SSIs), antibiotic exposure and direct antibiotic costs were compared between pre-intervention and intervention periods. Significant improvement in mean SAP duration (by 42.9%, 4.08 &#177; 2.08 vs. 2.08 &#177; 1.90 days, <i title="valid: False, node: 691, tag: i, level: 15" node_number="691">p</i> &#706; 0.001), and overall guideline adherence regarding antibiotic use (by 56.2%, from 2% to 58.2%, <i title="valid: False, node: 692, tag: i, level: 15" node_number="692">p</i> &#706; 0.001) were observed. A significant decrease was observed in antibiotic exposure in SAP (by 41%, from 6.07 &#177; 0.05 to 3.58 &#177; 4.33 DDD/patient, <i title="valid: False, node: 693, tag: i, level: 15" node_number="693">p</i> &#706; 0.001), average prophylactic antibiotic cost (by 54.8%, 9278.79 &#177; 6094.29 vs. 3598.16 &#177; 3354.55 HUF/patient), and mean LOS (by 37.2%, from 11.22 &#177; 6.96 to 7.62 &#177; 3.02 days, <i title="valid: False, node: 694, tag: i, level: 15" node_number="694">p</i> &lt; 0.001); and a slight decrease in the number of confirmed SSIs was found between the two periods (by 1.8%, from 3% to 1.2%, <i title="valid: False, node: 695, tag: i, level: 15" node_number="695">p</i> = 0.21). Continuous presence of the clinical pharmacist led to significant improvement in SAP guideline adherence, which was accompanied by decreased antibiotic exposure and cost. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 696, tag: div, level: 13" node_number="696"> (This article belongs to the Special Issue Antibiotic Use in European Hospitals and Pharmacies) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 697, tag: div, level: 13" node_number="697"><div class="valid" valid="valid" title="valid: True, node: 698, tag: div, level: 14" node_number="698"><div title="valid: False, node: 699, tag: div, level: 15" node_number="699"><p title="valid: False, node: 700, tag: p, level: 16" node_number="700">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 701, tag: div, level: 10" node_number="701"> <div class="valid" valid="valid" title="valid: True, node: 702, tag: div, level: 11" node_number="702"> <div class="valid" valid="valid" title="valid: True, node: 703, tag: div, level: 12" node_number="703"> <div class="valid" valid="valid" title="valid: True, node: 704, tag: div, level: 13" node_number="704"> <a class="valid" valid="valid" title="valid: True, node: 705, tag: a, level: 14" node_number="705"> <i title="valid: False, node: 706, tag: i, level: 15" node_number="706">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 707, tag: div, level: 13" node_number="707"> <a class="valid" valid="valid" title="valid: True, node: 708, tag: a, level: 14" node_number="708"> <i title="valid: False, node: 709, tag: i, level: 15" node_number="709">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 710, tag: div, level: 14" node_number="710"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 711, tag: div, level: 13" node_number="711">Open AccessSystematic Review</div> <a class="valid" valid="valid" title="valid: True, node: 712, tag: a, level: 13" node_number="712">Global Prevalence of Nosocomial Multidrug-Resistant <i class="valid" valid="valid" title="valid: True, node: 713, tag: i, level: 14" node_number="713">Klebsiella pneumoniae</i>: A Systematic Review and Meta-Analysis</a> <div class="valid" valid="valid" title="valid: True, node: 714, tag: div, level: 13" node_number="714"> by <span class="valid" valid="valid" title="valid: True, node: 715, tag: span, level: 14" node_number="715"><div title="valid: False, node: 716, tag: div, level: 15" node_number="716">Nur Ain Mohd Asri</div>, </span><span class="valid" valid="valid" title="valid: True, node: 717, tag: span, level: 14" node_number="717"><div title="valid: False, node: 718, tag: div, level: 15" node_number="718">Suhana Ahmad</div>, </span><span class="valid" valid="valid" title="valid: True, node: 719, tag: span, level: 14" node_number="719"><div title="valid: False, node: 720, tag: div, level: 15" node_number="720">Rohimah Mohamud</div>, </span><span class="valid" valid="valid" title="valid: True, node: 721, tag: span, level: 14" node_number="721"><div title="valid: False, node: 722, tag: div, level: 15" node_number="722">Nurmardhiah Mohd Hanafi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 723, tag: span, level: 14" node_number="723"><div title="valid: False, node: 724, tag: div, level: 15" node_number="724">Nur Fatihah Mohd Zaidi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 725, tag: span, level: 14" node_number="725"><div title="valid: False, node: 726, tag: div, level: 15" node_number="726">Ahmad Adebayo Irekeola</div>, </span><span class="valid" valid="valid" title="valid: True, node: 727, tag: span, level: 14" node_number="727"><div title="valid: False, node: 728, tag: div, level: 15" node_number="728">Rafidah Hanim Shueb</div>, </span><span class="valid" valid="valid" title="valid: True, node: 729, tag: span, level: 14" node_number="729"><div title="valid: False, node: 730, tag: div, level: 15" node_number="730">Leow Chiuan Yee</div>, </span><span class="valid" valid="valid" title="valid: True, node: 731, tag: span, level: 14" node_number="731"><div title="valid: False, node: 732, tag: div, level: 15" node_number="732">Norhayati Mohd Noor</div>, </span><span class="valid" valid="valid" title="valid: True, node: 733, tag: span, level: 14" node_number="733"><div title="valid: False, node: 734, tag: div, level: 15" node_number="734">Fatin Hamimi Mustafa</div>, </span><span class="valid" valid="valid" title="valid: True, node: 735, tag: span, level: 14" node_number="735"><div title="valid: False, node: 736, tag: div, level: 15" node_number="736">Chan Yean Yean</div> and </span><span class="valid" valid="valid" title="valid: True, node: 737, tag: span, level: 14" node_number="737"><div title="valid: False, node: 738, tag: div, level: 15" node_number="738">Nik Yusnoraini Yusof</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 739, tag: div, level: 13" node_number="739"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 740, tag: b, level: 14" node_number="740">2021</b>, 10(12), 1508; https://doi.org/10.3390/antibiotics10121508 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 741, tag: div, level: 13" node_number="741"> Abstract <div class="valid" valid="valid" title="valid: True, node: 742, tag: div, level: 14" node_number="742"> The emergence of nosocomial multidrug-resistant <i title="valid: False, node: 743, tag: i, level: 15" node_number="743">Klebsiella pneumoniae</i> is an escalating public health threat worldwide. The prevalence of nosocomial infections due to <i title="valid: False, node: 744, tag: i, level: 15" node_number="744">K. pneumoniae</i> was recorded up to 10%. In this systematic review and meta-analysis, which were conducted according to the guidelines of Preferred [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 745, tag: div, level: 14" node_number="745"> The emergence of nosocomial multidrug-resistant <i title="valid: False, node: 746, tag: i, level: 15" node_number="746">Klebsiella pneumoniae</i> is an escalating public health threat worldwide. The prevalence of nosocomial infections due to <i title="valid: False, node: 747, tag: i, level: 15" node_number="747">K. pneumoniae</i> was recorded up to 10%. In this systematic review and meta-analysis, which were conducted according to the guidelines of Preferred Reporting Items for Systematic Review and Meta-Analysis, 1092 articles were screened from four databases of which 47 studies fulfilled the selected criteria. By performing a random-effect model, the pooled prevalence of nosocomial multidrug-resistant <i title="valid: False, node: 748, tag: i, level: 15" node_number="748">K. pneumoniae</i> was estimated at 32.8% (95% CI, 23.6&#8211;43.6), with high heterogeneity (I<sup title="valid: False, node: 749, tag: sup, level: 15" node_number="749">2</sup> 98.29%, <i title="valid: False, node: 750, tag: i, level: 15" node_number="750">p</i>-value &lt; 0.001). The estimated prevalence of this pathogen and a few related studies were discussed, raising awareness of the spread of multidrug-resistant <i title="valid: False, node: 751, tag: i, level: 15" node_number="751">K. pneumoniae</i> in the healthcare setting. The emergence of nosocomial multidrug-resistant <i title="valid: False, node: 752, tag: i, level: 15" node_number="752">K. pneumoniae</i> is expected to increase globally in the future, and the best treatments for treating and preventing this pathogen should be acknowledged by healthcare staff. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 753, tag: div, level: 13" node_number="753"> (This article belongs to the Special Issue Healthcare Infections, Healthcare Environment and Antimicrobial Resistance) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 754, tag: div, level: 13" node_number="754"><div class="valid" valid="valid" title="valid: True, node: 755, tag: div, level: 14" node_number="755"><div title="valid: False, node: 756, tag: div, level: 15" node_number="756"><p title="valid: False, node: 757, tag: p, level: 16" node_number="757">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 758, tag: div, level: 10" node_number="758"> <div class="valid" valid="valid" title="valid: True, node: 759, tag: div, level: 11" node_number="759"> <div class="valid" valid="valid" title="valid: True, node: 760, tag: div, level: 12" node_number="760"> <div class="valid" valid="valid" title="valid: True, node: 761, tag: div, level: 13" node_number="761"> <a class="valid" valid="valid" title="valid: True, node: 762, tag: a, level: 14" node_number="762"> <i title="valid: False, node: 763, tag: i, level: 15" node_number="763">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 764, tag: div, level: 14" node_number="764"> Supplementary material: Supplementary File 1 (ZIP, 670 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 765, tag: div, level: 13" node_number="765"> <a class="valid" valid="valid" title="valid: True, node: 766, tag: a, level: 14" node_number="766"> <i title="valid: False, node: 767, tag: i, level: 15" node_number="767">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 768, tag: div, level: 13" node_number="768"> <a class="valid" valid="valid" title="valid: True, node: 769, tag: a, level: 14" node_number="769"> <i title="valid: False, node: 770, tag: i, level: 15" node_number="770">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 771, tag: div, level: 14" node_number="771"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 772, tag: div, level: 13" node_number="772">Open AccessArticle</div> A Closer Look at Dexamethasone and the SARS-CoV-2-Induced Cytokine Storm: In Silico Insights of the First Life-Saving COVID-19 Drug <div class="valid" valid="valid" title="valid: True, node: 773, tag: div, level: 13" node_number="773"> by <span class="valid" valid="valid" title="valid: True, node: 774, tag: span, level: 14" node_number="774"><div title="valid: False, node: 775, tag: div, level: 15" node_number="775">Paul Morgan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 776, tag: span, level: 14" node_number="776"><div title="valid: False, node: 777, tag: div, level: 15" node_number="777">Shareen J. Arnold</div>, </span><span class="valid" valid="valid" title="valid: True, node: 778, tag: span, level: 14" node_number="778"><div title="valid: False, node: 779, tag: div, level: 15" node_number="779">Nai-Wan Hsiao</div> and </span><span class="valid" valid="valid" title="valid: True, node: 780, tag: span, level: 14" node_number="780"><div title="valid: False, node: 781, tag: div, level: 15" node_number="781">Chih-Wen Shu</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 782, tag: div, level: 13" node_number="782"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 783, tag: b, level: 14" node_number="783">2021</b>, 10(12), 1507; https://doi.org/10.3390/antibiotics10121507 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 784, tag: div, level: 13" node_number="784"> Abstract <div class="valid" valid="valid" title="valid: True, node: 785, tag: div, level: 14" node_number="785"> The term cytokine storm refers to an uncontrolled overproduction of soluble inflammatory markers known as cytokines and chemokines. Autoimmune destruction of the lungs triggered by the release of these inflammatory markers often induces acute respiratory distress syndrome (ARDS). ARDS is an emergency condition [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 786, tag: div, level: 14" node_number="786"> The term cytokine storm refers to an uncontrolled overproduction of soluble inflammatory markers known as cytokines and chemokines. Autoimmune destruction of the lungs triggered by the release of these inflammatory markers often induces acute respiratory distress syndrome (ARDS). ARDS is an emergency condition with a high mortality rate in COVID-19 patients. Dexamethasone is the first repurposed corticosteroid with life-saving efficacy in patients with severe SARS-CoV-2 infection. Dexamethasone has traditionally been known to suppress the production of inflammatory markers at the transcriptional level, but its role as a direct therapeutic to neutralize cytokines, chemokines, their receptors, and functionally critical SARS-CoV-2 proteins has not yet been explored. Herein, we demonstrated that dexamethasone binds with high affinity to interlukin-1 (IL-1), IL-6, IL-8, IL-12, IL-21, INF2, TGF&#946;-1, INF-&#947;, CXCL8, some of the receptors, IL-1R, IL-21R, IFNGR, INFAR, IL-6&#945;R-gp130, ST2 and the SARS-CoV-2 protein NSP macro X, and 3CLpro, forming stable drug&#8211;protein complexes. Our work implied that dexamethasone has the potential to directly neutralize inflammatory markers, further supporting its life-saving potential in patients with severe manifestations of COVID-19. Full article </div> </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 787, tag: div, level: 13" node_number="787"><div class="valid" valid="valid" title="valid: True, node: 788, tag: div, level: 14" node_number="788"><div title="valid: False, node: 789, tag: div, level: 15" node_number="789"><p title="valid: False, node: 790, tag: p, level: 16" node_number="790">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 791, tag: div, level: 10" node_number="791"> <div class="valid" valid="valid" title="valid: True, node: 792, tag: div, level: 11" node_number="792"> <div class="valid" valid="valid" title="valid: True, node: 793, tag: div, level: 12" node_number="793"> <div class="valid" valid="valid" title="valid: True, node: 794, tag: div, level: 13" node_number="794"> <a class="valid" valid="valid" title="valid: True, node: 795, tag: a, level: 14" node_number="795"> <i title="valid: False, node: 796, tag: i, level: 15" node_number="796">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 797, tag: div, level: 13" node_number="797"> <a class="valid" valid="valid" title="valid: True, node: 798, tag: a, level: 14" node_number="798"> <i title="valid: False, node: 799, tag: i, level: 15" node_number="799">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 800, tag: div, level: 14" node_number="800"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 801, tag: div, level: 13" node_number="801">Open AccessReview</div> Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline <div class="valid" valid="valid" title="valid: True, node: 802, tag: div, level: 13" node_number="802"> by <span class="valid" valid="valid" title="valid: True, node: 803, tag: span, level: 14" node_number="803"><div title="valid: False, node: 804, tag: div, level: 15" node_number="804">B&#233;la Kocsis</div>, </span><span class="valid" valid="valid" title="valid: True, node: 805, tag: span, level: 14" node_number="805"><div title="valid: False, node: 806, tag: div, level: 15" node_number="806">D&#225;niel Guly&#225;s</div> and </span><span class="valid" valid="valid" title="valid: True, node: 807, tag: span, level: 14" node_number="807"><div title="valid: False, node: 808, tag: div, level: 15" node_number="808">D&#243;ra Szab&#243;</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 809, tag: div, level: 13" node_number="809"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 810, tag: b, level: 14" node_number="810">2021</b>, 10(12), 1506; https://doi.org/10.3390/antibiotics10121506 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 811, tag: div, level: 13" node_number="811"> Abstract <div class="valid" valid="valid" title="valid: True, node: 812, tag: div, level: 14" node_number="812"> Novel antimicrobial agents, approved for clinical use in past years, represent potential treatment options for various infections. In this review, we summarize the most important medical and microbiological features of three recently approved fluoroquinolones, namely delafloxacin, finafloxacin, and zabofloxacin. Delafloxacin possesses an anionic [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 813, tag: div, level: 14" node_number="813"> Novel antimicrobial agents, approved for clinical use in past years, represent potential treatment options for various infections. In this review, we summarize the most important medical and microbiological features of three recently approved fluoroquinolones, namely delafloxacin, finafloxacin, and zabofloxacin. Delafloxacin possesses an anionic chemical structure, and represents broad-spectrum activity, as it targets both bacterial DNA gyrase and topoisomerase IV enzymes of gram-positive and gram-negative bacteria with equal affinity. Its molecular surface is larger than that of other fluoroquinolones, and it has enhanced antibacterial efficacy in acidic environments. Delafloxacin has been approved to treat acute bacterial skin and skin-structure infections, as well as community-acquired bacterial pneumonia. Finafloxacin has a zwitterionic chemical structure, and targets both DNA gyrase and topoisomerase IV enzymes. This enables a broad antibacterial spectrum; however, finafloxacin has so far only been approved in ear-drops to treat bacterial otitis externa. Zabofloxacin is also a broad-spectrum fluoroquinolone agent, and was first approved in South Korea to treat acute bacterial exacerbation of chronic obstructive pulmonary disease. The introduction of these novel fluoroquinolones into daily practice extends the possible indications of antibiotics into different bacterial infections, and provides treatment options in difficult-to-treat infections. However, some reports of delafloxacin resistance have already appeared, thus underlining the importance of the prudent use of antibiotics. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 814, tag: div, level: 13" node_number="814"> (This article belongs to the Special Issue 10th Anniversary of Antibiotics - Recent Advances in Novel Antimicrobial Agents) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 815, tag: div, level: 13" node_number="815"><div class="valid" valid="valid" title="valid: True, node: 816, tag: div, level: 14" node_number="816"><div title="valid: False, node: 817, tag: div, level: 15" node_number="817"><p title="valid: False, node: 818, tag: p, level: 16" node_number="818">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 819, tag: div, level: 10" node_number="819"> <div class="valid" valid="valid" title="valid: True, node: 820, tag: div, level: 11" node_number="820"> <div class="valid" valid="valid" title="valid: True, node: 821, tag: div, level: 12" node_number="821"> <div class="valid" valid="valid" title="valid: True, node: 822, tag: div, level: 13" node_number="822"> <a class="valid" valid="valid" title="valid: True, node: 823, tag: a, level: 14" node_number="823"> <i title="valid: False, node: 824, tag: i, level: 15" node_number="824">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 825, tag: div, level: 13" node_number="825"> <a class="valid" valid="valid" title="valid: True, node: 826, tag: a, level: 14" node_number="826"> <i title="valid: False, node: 827, tag: i, level: 15" node_number="827">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 828, tag: div, level: 14" node_number="828"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 829, tag: div, level: 13" node_number="829">Open AccessReview</div> Alkaloids as Photosensitisers for the Inactivation of Bacteria <div class="valid" valid="valid" title="valid: True, node: 830, tag: div, level: 13" node_number="830"> by <span class="valid" valid="valid" title="valid: True, node: 831, tag: span, level: 14" node_number="831"><div title="valid: False, node: 832, tag: div, level: 15" node_number="832">S&#242;nia L&#243;pez-Molina</div>, </span><span class="valid" valid="valid" title="valid: True, node: 833, tag: span, level: 14" node_number="833"><div title="valid: False, node: 834, tag: div, level: 15" node_number="834">Cristina Galiana-Rosell&#243;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 835, tag: span, level: 14" node_number="835"><div title="valid: False, node: 836, tag: div, level: 15" node_number="836">Carolina Galiana</div>, </span><span class="valid" valid="valid" title="valid: True, node: 837, tag: span, level: 14" node_number="837"><div title="valid: False, node: 838, tag: div, level: 15" node_number="838">Ariadna Gil-Mart&#237;nez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 839, tag: span, level: 14" node_number="839"><div title="valid: False, node: 840, tag: div, level: 15" node_number="840">Stephane Bandeira</div> and </span><span class="valid" valid="valid" title="valid: True, node: 841, tag: span, level: 14" node_number="841"><div title="valid: False, node: 842, tag: div, level: 15" node_number="842">Jorge Gonz&#225;lez-Garc&#237;a</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 843, tag: div, level: 13" node_number="843"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 844, tag: b, level: 14" node_number="844">2021</b>, 10(12), 1505; https://doi.org/10.3390/antibiotics10121505 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 845, tag: div, level: 13" node_number="845"> Abstract <div class="valid" valid="valid" title="valid: True, node: 846, tag: div, level: 14" node_number="846"> Antimicrobial photodynamic therapy has emerged as a powerful approach to tackle microbial infections. Photodynamic therapy utilises a photosensitiser, light, and oxygen to generate singlet oxygen and/or reactive oxygen species in an irradiated tissue spot, which subsequently react with nearby biomolecules and destroy the [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 847, tag: div, level: 14" node_number="847"> Antimicrobial photodynamic therapy has emerged as a powerful approach to tackle microbial infections. Photodynamic therapy utilises a photosensitiser, light, and oxygen to generate singlet oxygen and/or reactive oxygen species in an irradiated tissue spot, which subsequently react with nearby biomolecules and destroy the cellular environment. Due to the possibility to irradiate in a very precise location, it can be used to eradicate bacteria, fungus, and parasites upon light activation of the photosensitiser. In this regard, natural products are low-cost molecules capable of being obtained in large quantities, and some of them can be used as photosensitisers. Alkaloids are the largest family among natural products and include molecules with a basic nature and aromatic rings. For this study, we collected the naturally occurring alkaloids used to treat microorganism infections using a photodynamic inactivation approach. We gathered their main photophysical properties (excitation/emission wavelengths, quantum yields, and oxygen quantum yield) which characterise the ability to efficiently photosensitise. In addition, we described the antibacterial activity of alkaloids upon irradiation and the mechanisms involved in the microorganism killing. This review will serve as a reference source to obtain the main information on alkaloids used in antimicrobial photodynamic therapy. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 848, tag: div, level: 13" node_number="848"> (This article belongs to the Special Issue Search of New Natural Products with Antimicrobial Activity) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 849, tag: div, level: 13" node_number="849"><div class="valid" valid="valid" title="valid: True, node: 850, tag: div, level: 14" node_number="850"><div title="valid: False, node: 851, tag: div, level: 15" node_number="851"><p title="valid: False, node: 852, tag: p, level: 16" node_number="852">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 853, tag: div, level: 10" node_number="853"> <div class="valid" valid="valid" title="valid: True, node: 854, tag: div, level: 11" node_number="854"> <div class="valid" valid="valid" title="valid: True, node: 855, tag: div, level: 12" node_number="855"> <div class="valid" valid="valid" title="valid: True, node: 856, tag: div, level: 13" node_number="856"> <a class="valid" valid="valid" title="valid: True, node: 857, tag: a, level: 14" node_number="857"> <i title="valid: False, node: 858, tag: i, level: 15" node_number="858">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 859, tag: div, level: 14" node_number="859"> Supplementary material: Supplementary File 1 (ZIP, 1230 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 860, tag: div, level: 13" node_number="860"> <a class="valid" valid="valid" title="valid: True, node: 861, tag: a, level: 14" node_number="861"> <i title="valid: False, node: 862, tag: i, level: 15" node_number="862">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 863, tag: div, level: 13" node_number="863"> <a class="valid" valid="valid" title="valid: True, node: 864, tag: a, level: 14" node_number="864"> <i title="valid: False, node: 865, tag: i, level: 15" node_number="865">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 866, tag: div, level: 14" node_number="866"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 867, tag: div, level: 13" node_number="867">Open AccessArticle</div> Analysis of Plant Origin Antibiotics against Oral Bacterial Infections Using In Vitro and In Silico Techniques and Characterization of Active Constituents <div class="valid" valid="valid" title="valid: True, node: 868, tag: div, level: 13" node_number="868"> by <span class="valid" valid="valid" title="valid: True, node: 869, tag: span, level: 14" node_number="869"><div title="valid: False, node: 870, tag: div, level: 15" node_number="870">Abdul Rafey</div>, </span><span class="valid" valid="valid" title="valid: True, node: 871, tag: span, level: 14" node_number="871"><div title="valid: False, node: 872, tag: div, level: 15" node_number="872">Adnan Amin</div>, </span><span class="valid" valid="valid" title="valid: True, node: 873, tag: span, level: 14" node_number="873"><div title="valid: False, node: 874, tag: div, level: 15" node_number="874">Muhammad Kamran</div>, </span><span class="valid" valid="valid" title="valid: True, node: 875, tag: span, level: 14" node_number="875"><div title="valid: False, node: 876, tag: div, level: 15" node_number="876">Uzma Haroon</div>, </span><span class="valid" valid="valid" title="valid: True, node: 877, tag: span, level: 14" node_number="877"><div title="valid: False, node: 878, tag: div, level: 15" node_number="878">Kainat Farooq</div>, </span><span class="valid" valid="valid" title="valid: True, node: 879, tag: span, level: 14" node_number="879"><div title="valid: False, node: 880, tag: div, level: 15" node_number="880">Kenn Foubert</div> and </span><span class="valid" valid="valid" title="valid: True, node: 881, tag: span, level: 14" node_number="881"><div title="valid: False, node: 882, tag: div, level: 15" node_number="882">Luc Pieters</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 883, tag: div, level: 13" node_number="883"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 884, tag: b, level: 14" node_number="884">2021</b>, 10(12), 1504; https://doi.org/10.3390/antibiotics10121504 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 885, tag: div, level: 13" node_number="885"> Abstract <div class="valid" valid="valid" title="valid: True, node: 886, tag: div, level: 14" node_number="886"> The pervasiveness of oral bacterial infections in diabetic patients is a serious health concern that may produce severe complications. We investigated 26 Ayurvedic medicinal plants traditionally used for treatment of the oral bacterial infections with the aim to look for new promising drug [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 887, tag: div, level: 14" node_number="887"> The pervasiveness of oral bacterial infections in diabetic patients is a serious health concern that may produce severe complications. We investigated 26 Ayurvedic medicinal plants traditionally used for treatment of the oral bacterial infections with the aim to look for new promising drug leads that can be further employed for herbal formulation design. The plants were grouped into three categories based on traditional usage. All plant extracts were examined for antibacterial, antibiofilm and antiquorum-sensing properties. The plants with significant activities including <i title="valid: False, node: 888, tag: i, level: 15" node_number="888">Juglans regia</i>, <i title="valid: False, node: 889, tag: i, level: 15" node_number="889">Syzygium aromaticum</i>, <i title="valid: False, node: 890, tag: i, level: 15" node_number="890">Eruca sativa</i>, <i title="valid: False, node: 891, tag: i, level: 15" node_number="891">Myristica fragrans</i>, <i title="valid: False, node: 892, tag: i, level: 15" node_number="892">Punica granatum</i> and <i title="valid: False, node: 893, tag: i, level: 15" node_number="893">Azadirachta indica</i> were further analyzed using HPLC-DAD-QToF and GC-MS. In silico and in vitro activity was evaluated for selected constituents. Finally, it could be concluded that eugenol and 2-phenylethylisothiocyanate are major contributors towards inhibition of bacterial biofilms and quorum sensing. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 894, tag: div, level: 13" node_number="894"> (This article belongs to the Special Issue Design and Preparation of Antimicrobial Agents) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 895, tag: div, level: 13" node_number="895"><div class="valid" valid="valid" title="valid: True, node: 896, tag: div, level: 14" node_number="896"><div title="valid: False, node: 897, tag: div, level: 15" node_number="897"><p title="valid: False, node: 898, tag: p, level: 16" node_number="898">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 899, tag: div, level: 10" node_number="899"> <div class="valid" valid="valid" title="valid: True, node: 900, tag: div, level: 11" node_number="900"> <div class="valid" valid="valid" title="valid: True, node: 901, tag: div, level: 12" node_number="901"> <div class="valid" valid="valid" title="valid: True, node: 902, tag: div, level: 13" node_number="902"> <a class="valid" valid="valid" title="valid: True, node: 903, tag: a, level: 14" node_number="903"> <i title="valid: False, node: 904, tag: i, level: 15" node_number="904">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 905, tag: div, level: 13" node_number="905"> <a class="valid" valid="valid" title="valid: True, node: 906, tag: a, level: 14" node_number="906"> <i title="valid: False, node: 907, tag: i, level: 15" node_number="907">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 908, tag: div, level: 14" node_number="908"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 909, tag: div, level: 13" node_number="909">Open AccessArticle</div> Comparative Study of Antimicrobial Properties of Bee Venom Extracts and Melittins of Honey Bees <div class="valid" valid="valid" title="valid: True, node: 910, tag: div, level: 13" node_number="910"> by <span class="valid" valid="valid" title="valid: True, node: 911, tag: span, level: 14" node_number="911"><div title="valid: False, node: 912, tag: div, level: 15" node_number="912">Jakkrawut Maitip</div>, </span><span class="valid" valid="valid" title="valid: True, node: 913, tag: span, level: 14" node_number="913"><div title="valid: False, node: 914, tag: div, level: 15" node_number="914">Wannapha Mookhploy</div>, </span><span class="valid" valid="valid" title="valid: True, node: 915, tag: span, level: 14" node_number="915"><div title="valid: False, node: 916, tag: div, level: 15" node_number="916">Supharerk Khorndork</div> and </span><span class="valid" valid="valid" title="valid: True, node: 917, tag: span, level: 14" node_number="917"><div title="valid: False, node: 918, tag: div, level: 15" node_number="918">Panuwan Chantawannakul</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 919, tag: div, level: 13" node_number="919"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 920, tag: b, level: 14" node_number="920">2021</b>, 10(12), 1503; https://doi.org/10.3390/antibiotics10121503 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 921, tag: div, level: 13" node_number="921"> Abstract <div class="valid" valid="valid" title="valid: True, node: 922, tag: div, level: 14" node_number="922"> Bee venom (BV), or apitoxin, is a complex substance produced by a gland in the abdominal cavity of bees. The main component of BV is melittin, which is a largely studied substance due to its biological properties. To date, the most well-known bee [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 923, tag: div, level: 14" node_number="923"> Bee venom (BV), or apitoxin, is a complex substance produced by a gland in the abdominal cavity of bees. The main component of BV is melittin, which is a largely studied substance due to its biological properties. To date, the most well-known bee venom and melittin are derived from domesticated honey bees, while venom and melittin derived from wild honey bees have been under-investigated. Hence, this study primarily reports the antimicrobial activities of bee venom and synthetic melittin derived from four different honey bee species (<i title="valid: False, node: 924, tag: i, level: 15" node_number="924">Apis mellifera</i>, <i title="valid: False, node: 925, tag: i, level: 15" node_number="925">A. cerana, A. dorsata</i>, and <i title="valid: False, node: 926, tag: i, level: 15" node_number="926">A. florea</i>) in Thailand. All the bee venom extracts and melittins showed more robust antibacterial activities against Gram-positive (<i title="valid: False, node: 927, tag: i, level: 15" node_number="927">Bacillus subtilis</i>, <i title="valid: False, node: 928, tag: i, level: 15" node_number="928">Micrococcus luteus</i>, <i title="valid: False, node: 929, tag: i, level: 15" node_number="929">Staphylococcus aureus</i>, <i title="valid: False, node: 930, tag: i, level: 15" node_number="930">S. aureus MRSA</i>, and <i title="valid: False, node: 931, tag: i, level: 15" node_number="931">S. epidermidis</i>) than Gram-negative bacteria (<i title="valid: False, node: 932, tag: i, level: 15" node_number="932">Escherichia coli</i>, <i title="valid: False, node: 933, tag: i, level: 15" node_number="933">Klebsiella pneuminiae</i>, and <i title="valid: False, node: 934, tag: i, level: 15" node_number="934">Salmonella typhimurium</i>) or a fungus (<i title="valid: False, node: 935, tag: i, level: 15" node_number="935">Candida albicans</i>), while the synthetic melittins also have antimicrobial activity at higher concentrations than the bee venom extract. Furthermore, the <i title="valid: False, node: 936, tag: i, level: 15" node_number="936">A. cerana</i> venom extract showed the highest activity against the tested bacteria, followed by <i title="valid: False, node: 937, tag: i, level: 15" node_number="937">A. mellifera</i>, <i title="valid: False, node: 938, tag: i, level: 15" node_number="938">A. florea,</i> and <i title="valid: False, node: 939, tag: i, level: 15" node_number="939">A. dorsata</i>. Therefore, <i title="valid: False, node: 940, tag: i, level: 15" node_number="940">A. cerana</i> venom may be further developed for use in medical applications as a potential alternative agent against Gram-positive bacteria and antibiotic-resistant bacteria. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 941, tag: div, level: 13" node_number="941"> (This article belongs to the Special Issue Novel Antibiotics and Novel Modes of Action to Fight Infectious Diseases in Antimicrobial Resistance Era) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 942, tag: div, level: 13" node_number="942"><div class="valid" valid="valid" title="valid: True, node: 943, tag: div, level: 14" node_number="943"><div title="valid: False, node: 944, tag: div, level: 15" node_number="944"><p title="valid: False, node: 945, tag: p, level: 16" node_number="945">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 946, tag: div, level: 10" node_number="946"> <div class="valid" valid="valid" title="valid: True, node: 947, tag: div, level: 11" node_number="947"> <div class="valid" valid="valid" title="valid: True, node: 948, tag: div, level: 12" node_number="948"> <div class="valid" valid="valid" title="valid: True, node: 949, tag: div, level: 13" node_number="949"> <a class="valid" valid="valid" title="valid: True, node: 950, tag: a, level: 14" node_number="950"> <i title="valid: False, node: 951, tag: i, level: 15" node_number="951">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 952, tag: div, level: 13" node_number="952"> <a class="valid" valid="valid" title="valid: True, node: 953, tag: a, level: 14" node_number="953"> <i title="valid: False, node: 954, tag: i, level: 15" node_number="954">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 955, tag: div, level: 14" node_number="955"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 956, tag: div, level: 13" node_number="956">Open AccessReview</div> Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition <div class="valid" valid="valid" title="valid: True, node: 957, tag: div, level: 13" node_number="957"> by <span class="valid" valid="valid" title="valid: True, node: 958, tag: span, level: 14" node_number="958"><div title="valid: False, node: 959, tag: div, level: 15" node_number="959">Abolfazl Dashtbani-Roozbehani</div> and </span><span class="valid" valid="valid" title="valid: True, node: 960, tag: span, level: 14" node_number="960"><div title="valid: False, node: 961, tag: div, level: 15" node_number="961">Melissa H. Brown</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 962, tag: div, level: 13" node_number="962"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 963, tag: b, level: 14" node_number="963">2021</b>, 10(12), 1502; https://doi.org/10.3390/antibiotics10121502 - 07 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 964, tag: div, level: 13" node_number="964"> Abstract <div class="valid" valid="valid" title="valid: True, node: 965, tag: div, level: 14" node_number="965"> The increasing emergence of antimicrobial resistance in staphylococcal bacteria is a major health threat worldwide due to significant morbidity and mortality resulting from their associated hospital- or community-acquired infections. Dramatic decrease in the discovery of new antibiotics from the pharmaceutical industry coupled with [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 966, tag: div, level: 14" node_number="966"> The increasing emergence of antimicrobial resistance in staphylococcal bacteria is a major health threat worldwide due to significant morbidity and mortality resulting from their associated hospital- or community-acquired infections. Dramatic decrease in the discovery of new antibiotics from the pharmaceutical industry coupled with increased use of sanitisers and disinfectants due to the ongoing COVID-19 pandemic can further aggravate the problem of antimicrobial resistance. Staphylococci utilise multiple mechanisms to circumvent the effects of antimicrobials. One of these resistance mechanisms is the export of antimicrobial agents through the activity of membrane-embedded multidrug efflux pump proteins. The use of efflux pump inhibitors in combination with currently approved antimicrobials is a promising strategy to potentiate their clinical efficacy against resistant strains of staphylococci, and simultaneously reduce the selection of resistant mutants. This review presents an overview of the current knowledge of staphylococcal efflux pumps, discusses their clinical impact, and summarises compounds found in the last decade from plant and synthetic origin that have the potential to be used as adjuvants to antibiotic therapy against multidrug resistant staphylococci. Critically, future high-resolution structures of staphylococcal efflux pumps could aid in design and development of safer, more target-specific and highly potent efflux pump inhibitors to progress into clinical use. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 967, tag: div, level: 13" node_number="967"> (This article belongs to the Special Issue Antibacterial, Antibiofilm and Anti-virulence Activity Research of Both Natural and Synthetic Products) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 968, tag: div, level: 13" node_number="968"><div class="valid" valid="valid" title="valid: True, node: 969, tag: div, level: 14" node_number="969"><div title="valid: False, node: 970, tag: div, level: 15" node_number="970"><p title="valid: False, node: 971, tag: p, level: 16" node_number="971">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 972, tag: div, level: 10" node_number="972"> <div class="valid" valid="valid" title="valid: True, node: 973, tag: div, level: 11" node_number="973"> <div class="valid" valid="valid" title="valid: True, node: 974, tag: div, level: 12" node_number="974"> <div class="valid" valid="valid" title="valid: True, node: 975, tag: div, level: 13" node_number="975"> <a class="valid" valid="valid" title="valid: True, node: 976, tag: a, level: 14" node_number="976"> <i title="valid: False, node: 977, tag: i, level: 15" node_number="977">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 978, tag: div, level: 14" node_number="978"> Supplementary material: Supplementary File 1 (ZIP, 313 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 979, tag: div, level: 13" node_number="979"> <a class="valid" valid="valid" title="valid: True, node: 980, tag: a, level: 14" node_number="980"> <i title="valid: False, node: 981, tag: i, level: 15" node_number="981">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 982, tag: div, level: 13" node_number="982"> <a class="valid" valid="valid" title="valid: True, node: 983, tag: a, level: 14" node_number="983"> <i title="valid: False, node: 984, tag: i, level: 15" node_number="984">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 985, tag: div, level: 14" node_number="985"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 986, tag: div, level: 13" node_number="986">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 987, tag: a, level: 13" node_number="987">Influence of Nisin-Biogel at Subinhibitory Concentrations on Virulence Expression in <i class="valid" valid="valid" title="valid: True, node: 988, tag: i, level: 14" node_number="988">Staphylococcus aureus</i> Isolates from Diabetic Foot Infections</a> <div class="valid" valid="valid" title="valid: True, node: 989, tag: div, level: 13" node_number="989"> by <span class="valid" valid="valid" title="valid: True, node: 990, tag: span, level: 14" node_number="990"><div title="valid: False, node: 991, tag: div, level: 15" node_number="991">Carolina Jesus</div>, </span><span class="valid" valid="valid" title="valid: True, node: 992, tag: span, level: 14" node_number="992"><div title="valid: False, node: 993, tag: div, level: 15" node_number="993">Rui Soares</div>, </span><span class="valid" valid="valid" title="valid: True, node: 994, tag: span, level: 14" node_number="994"><div title="valid: False, node: 995, tag: div, level: 15" node_number="995">Eva Cunha</div>, </span><span class="valid" valid="valid" title="valid: True, node: 996, tag: span, level: 14" node_number="996"><div title="valid: False, node: 997, tag: div, level: 15" node_number="997">Miguel Grilo</div>, </span><span class="valid" valid="valid" title="valid: True, node: 998, tag: span, level: 14" node_number="998"><div title="valid: False, node: 999, tag: div, level: 15" node_number="999">Lu&#237;s Tavares</div> and </span><span class="valid" valid="valid" title="valid: True, node: 1000, tag: span, level: 14" node_number="1000"><div title="valid: False, node: 1001, tag: div, level: 15" node_number="1001">Manuela Oliveira</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 1002, tag: div, level: 13" node_number="1002"> Antibiotics <b class="valid" valid="valid" title="valid: True, node: 1003, tag: b, level: 14" node_number="1003">2021</b>, 10(12), 1501; https://doi.org/10.3390/antibiotics10121501 - 07 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 1004, tag: div, level: 13" node_number="1004"> Abstract <div class="valid" valid="valid" title="valid: True, node: 1005, tag: div, level: 14" node_number="1005"> A new approach to diabetic foot infections (DFIs) has been investigated, using a nisin-biogel combining the antimicrobial peptide (AMP) nisin with the natural polysaccharide guar-gum. Since in in vivo conditions bacteria may be exposed to decreased antimicrobial concentrations, known as subinhibitory concentrations (sub-MICs), [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 1006, tag: div, level: 14" node_number="1006"> A new approach to diabetic foot infections (DFIs) has been investigated, using a nisin-biogel combining the antimicrobial peptide (AMP) nisin with the natural polysaccharide guar-gum. Since in in vivo conditions bacteria may be exposed to decreased antimicrobial concentrations, known as subinhibitory concentrations (sub-MICs), effects of nisin-biogel sub-MIC values corresponding to 1/2, 1/4 and 1/8 of nisin&#8217;s minimum inhibitory concentration (MIC) on virulence expression by six <i title="valid: False, node: 1007, tag: i, level: 15" node_number="1007">Staphylococcus aureus</i> DFI isolates was evaluated by determining bacteria growth rate; expression of genes encoding for staphylococcal protein A (<i title="valid: False, node: 1008, tag: i, level: 15" node_number="1008">spA</i>), coagulase (<i title="valid: False, node: 1009, tag: i, level: 15" node_number="1009">coa</i>), clumping factor A (<i title="valid: False, node: 1010, tag: i, level: 15" node_number="1010">clfA</i>), autolysin (<i title="valid: False, node: 1011, tag: i, level: 15" node_number="1011">atl</i>), intracellular adhesin A (<i title="valid: False, node: 1012, tag: i, level: 15" node_number="1012">icaA</i>), intracellular adhesin D (<i title="valid: False, node: 1013, tag: i, level: 15" node_number="1013">icaD</i>), and the accessory gene regulator I (<i title="valid: False, node: 1014, tag: i, level: 15" node_number="1014">agrI</i>); biofilm formation; Coa production; and SpA release. Nisin-biogel sub-MICs decreased bacterial growth in a strain- and dose-dependent manner, decreased <i title="valid: False, node: 1015, tag: i, level: 15" node_number="1015">agrI</i>, <i title="valid: False, node: 1016, tag: i, level: 15" node_number="1016">atl</i> and <i title="valid: False, node: 1017, tag: i, level: 15" node_number="1017">clfA</i> expression, and increased <i title="valid: False, node: 1018, tag: i, level: 15" node_number="1018">spA</i>, <i title="valid: False, node: 1019, tag: i, level: 15" node_number="1019">coa</i>, <i title="valid: False, node: 1020, tag: i, level: 15" node_number="1020">icaA</i> and <i title="valid: False, node: 1021, tag: i, level: 15" node_number="1021">icaD</i> expression. Biofilm formation increased in the presence of nisin-biogel at 1/4 and 1/8 MIC, whereas 1/2 MIC had no effect. Finally, nisin-biogel at sub-MICs did not affect coagulase production, but decreased SpA production in a dose-dependent manner. Results highlight the importance of optimizing nisin-biogel doses before proceeding to in vivo trials, to reduce the risk of virulence factor&#8217;s up-regulation due to the presence of inappropriate antimicrobial concentrations. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1022, tag: div, level: 13" node_number="1022"> (This article belongs to the Special Issue Antimicrobial Resistance and Virulence - 2nd Volume) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 1023, tag: div, level: 13" node_number="1023"><div class="valid" valid="valid" title="valid: True, node: 1024, tag: div, level: 14" node_number="1024"><div title="valid: False, node: 1025, tag: div, level: 15" node_number="1025"><p title="valid: False, node: 1026, tag: p, level: 16" node_number="1026">Figure 1</p></div></div></div> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1027, tag: div, level: 9" node_number="1027"> More Articles... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1028, tag: div, level: 6" node_number="1028"> <div class="valid" valid="valid" title="valid: True, node: 1029, tag: div, level: 7" node_number="1029"> <div class="valid" valid="valid" title="valid: True, node: 1030, tag: div, level: 8" node_number="1030"> <div class="valid" valid="valid" title="valid: True, node: 1031, tag: div, level: 9" node_number="1031"> <a class="valid" valid="valid" title="valid: True, node: 1032, tag: a, level: 10" node_number="1032"> Submit to <i class="valid" valid="valid" title="valid: True, node: 1033, tag: i, level: 11" node_number="1033">Antibiotics</i> </a> Review for Antibiotics <div class="valid" valid="valid" title="valid: True, node: 1034, tag: div, level: 10" node_number="1034"> Share </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1035, tag: div, level: 9" node_number="1035"> <h2 class="valid" valid="valid" title="valid: True, node: 1036, tag: h2, level: 10" node_number="1036">Journal Menu</h2> &#9658; &#9660; Journal Menu <ul class="valid" valid="valid" title="valid: True, node: 1037, tag: ul, level: 10" node_number="1037"> <li class="valid" valid="valid" title="valid: True, node: 1038, tag: li, level: 11" node_number="1038"> <ul class="valid" valid="valid" title="valid: True, node: 1039, tag: ul, level: 12" node_number="1039"> <li class="valid" valid="valid" title="valid: True, node: 1040, tag: li, level: 13" node_number="1040"> Antibiotics Home </li> <li class="valid" valid="valid" title="valid: True, node: 1041, tag: li, level: 13" node_number="1041"> Aims Scope </li> <li class="valid" valid="valid" title="valid: True, node: 1042, tag: li, level: 13" node_number="1042"> Editorial Board </li> <li class="valid" valid="valid" title="valid: True, node: 1043, tag: li, level: 13" node_number="1043"> Reviewer Board </li> <li class="valid" valid="valid" title="valid: True, node: 1044, tag: li, level: 13" node_number="1044"> Topical Advisory Panel </li> <li class="valid" valid="valid" title="valid: True, node: 1045, tag: li, level: 13" node_number="1045"> Instructions for Authors </li> <li class="valid" valid="valid" title="valid: True, node: 1046, tag: li, level: 13" node_number="1046"> Special Issues </li> <li class="valid" valid="valid" title="valid: True, node: 1047, tag: li, level: 13" node_number="1047"> Sections Collections </li> <li class="valid" valid="valid" title="valid: True, node: 1048, tag: li, level: 13" node_number="1048"> Article Processing Charge </li> <li class="valid" valid="valid" title="valid: True, node: 1049, tag: li, level: 13" node_number="1049"> Indexing Archiving </li> <li class="valid" valid="valid" title="valid: True, node: 1050, tag: li, level: 13" node_number="1050"> Editor's Choice Articles </li> <li class="valid" valid="valid" title="valid: True, node: 1051, tag: li, level: 13" node_number="1051"> Most Cited Viewed </li> <li class="valid" valid="valid" title="valid: True, node: 1052, tag: li, level: 13" node_number="1052"> Journal Statistics </li> <li class="valid" valid="valid" title="valid: True, node: 1053, tag: li, level: 13" node_number="1053"> Journal History </li> <li class="valid" valid="valid" title="valid: True, node: 1054, tag: li, level: 13" node_number="1054"> Journal Awards </li> <li class="valid" valid="valid" title="valid: True, node: 1055, tag: li, level: 13" node_number="1055"> Conferences </li> <li class="valid" valid="valid" title="valid: True, node: 1056, tag: li, level: 13" node_number="1056"> Editorial Office </li> <li class="valid" valid="valid" title="valid: True, node: 1057, tag: li, level: 13" node_number="1057"> 10th Anniversary of Antibiotics </li> </ul> </li> </ul> </div> <h2 class="valid" valid="valid" title="valid: True, node: 1058, tag: h2, level: 9" node_number="1058">Journal Browser</h2> &#9658; &#9660; Journal Browser <div class="valid" valid="valid" title="valid: True, node: 1059, tag: div, level: 9" node_number="1059"> <div class="valid" valid="valid" title="valid: True, node: 1060, tag: div, level: 10" node_number="1060"> <ul class="valid" valid="valid" title="valid: True, node: 1061, tag: ul, level: 11" node_number="1061"> <li class="valid" valid="valid" title="valid: True, node: 1062, tag: li, level: 12" node_number="1062"> <a class="valid" valid="valid" title="valid: True, node: 1063, tag: a, level: 13" node_number="1063"> <i class="valid" valid="valid" title="valid: True, node: 1064, tag: i, level: 14" node_number="1064"> arrow_forward_ios </i> Forthcoming issue </a> <a class="valid" valid="valid" title="valid: True, node: 1065, tag: a, level: 13" node_number="1065"> <i class="valid" valid="valid" title="valid: True, node: 1066, tag: i, level: 14" node_number="1066"> arrow_forward_ios </i> Current issue </a> </li> <div class="valid" valid="valid" title="valid: True, node: 1067, tag: div, level: 12" node_number="1067"> <div class="valid" valid="valid" title="valid: True, node: 1068, tag: div, level: 13" node_number="1068"> <div class="valid" valid="valid" title="valid: True, node: 1069, tag: div, level: 14" node_number="1069"> <li title="valid: False, node: 1070, tag: li, level: 15" node_number="1070"> Vol.&#160;10&#160;(2021) </li> <li title="valid: False, node: 1071, tag: li, level: 15" node_number="1071"> Vol.&#160;9&#160;(2020) </li> <li title="valid: False, node: 1072, tag: li, level: 15" node_number="1072"> Vol.&#160;8&#160;(2019) </li> <li title="valid: False, node: 1073, tag: li, level: 15" node_number="1073"> Vol.&#160;7&#160;(2018) </li> <li title="valid: False, node: 1074, tag: li, level: 15" node_number="1074"> Vol.&#160;6&#160;(2017) </li> <li title="valid: False, node: 1075, tag: li, level: 15" node_number="1075"> Vol.&#160;5&#160;(2016) </li> <li title="valid: False, node: 1076, tag: li, level: 15" node_number="1076"> Vol.&#160;4&#160;(2015) </li> <li title="valid: False, node: 1077, tag: li, level: 15" node_number="1077"> Vol.&#160;3&#160;(2014) </li> <li title="valid: False, node: 1078, tag: li, level: 15" node_number="1078"> Vol.&#160;2&#160;(2013) </li> <li title="valid: False, node: 1079, tag: li, level: 15" node_number="1079"> Vol.&#160;1&#160;(2012) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1080, tag: div, level: 7" node_number="1080"> <div class="valid" valid="valid" title="valid: True, node: 1081, tag: div, level: 8" node_number="1081"> <h2 class="valid" valid="valid" title="valid: True, node: 1082, tag: h2, level: 9" node_number="1082">Highly Accessed Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1083, tag: div, level: 8" node_number="1083"> <div class="valid" valid="valid" title="valid: True, node: 1084, tag: div, level: 9" node_number="1084"> View More... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1085, tag: div, level: 7" node_number="1085"> <div class="valid" valid="valid" title="valid: True, node: 1086, tag: div, level: 8" node_number="1086"> <h2 class="valid" valid="valid" title="valid: True, node: 1087, tag: h2, level: 9" node_number="1087">Latest Books</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1088, tag: div, level: 8" node_number="1088"> <div class="valid" valid="valid" title="valid: True, node: 1089, tag: div, level: 9" node_number="1089"> More Open Access Books... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1090, tag: div, level: 6" node_number="1090"> <div class="valid" valid="valid" title="valid: True, node: 1091, tag: div, level: 7" node_number="1091"> <div class="valid" valid="valid" title="valid: True, node: 1092, tag: div, level: 8" node_number="1092"> <h2 class="valid" valid="valid" title="valid: True, node: 1093, tag: h2, level: 9" node_number="1093">E-Mail Alert</h2> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1094, tag: div, level: 7" node_number="1094"> <div class="valid" valid="valid" title="valid: True, node: 1095, tag: div, level: 8" node_number="1095"> <h2 class="valid" valid="valid" title="valid: True, node: 1096, tag: h2, level: 9" node_number="1096">News</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1097, tag: div, level: 8" node_number="1097"> <div class="valid" valid="valid" title="valid: True, node: 1098, tag: div, level: 9" node_number="1098"> 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div class="valid" valid="valid" title="valid: True, node: 1099, tag: div, level: 9" node_number="1099"> 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div class="valid" valid="valid" title="valid: True, node: 1100, tag: div, level: 9" node_number="1100"> 25 October 2021 Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25&#8211;31 October </div> <div class="valid" valid="valid" title="valid: True, node: 1101, tag: div, level: 9" node_number="1101"> More News Announcements... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1102, tag: div, level: 7" node_number="1102"> <div class="valid" valid="valid" title="valid: True, node: 1103, tag: div, level: 8" node_number="1103"> <h2 class="valid" valid="valid" title="valid: True, node: 1104, tag: h2, level: 9" node_number="1104">Topics</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1105, tag: div, level: 8" node_number="1105"> <div class="valid" valid="valid" title="valid: True, node: 1106, tag: div, level: 9" node_number="1106"><div class="valid" valid="valid" title="valid: True, node: 1107, tag: div, level: 10" node_number="1107"> Topic in Applied Sciences, Biomolecules, Pharmaceuticals, Biomedicines, Antibiotics</div> Compounds with Medicinal Value Editor-in-Chief: Maria Stefania SinicropiDeadline: 31 March 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1108, tag: div, level: 9" node_number="1108"><div class="valid" valid="valid" title="valid: True, node: 1109, tag: div, level: 10" node_number="1109"> Topic in Antibiotics, Pharmaceutics, Pharmaceuticals, MPs</div> Emerging Material-Based Approaches to Chronic and Infectious Diseases Editor-in-Chief: Alan J. HibbittsDeadline: 31 May 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1110, tag: div, level: 9" node_number="1110"><div class="valid" valid="valid" title="valid: True, node: 1111, tag: div, level: 10" node_number="1111"> Topic in Antibiotics, Antioxidants, JoF, Microbiology Research, Microorganisms</div> Redox in Microorganisms Deadline: 30 November 2022</div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1112, tag: div, level: 7" node_number="1112"> <div class="valid" valid="valid" title="valid: True, node: 1113, tag: div, level: 8" node_number="1113"> <h2 class="valid" valid="valid" title="valid: True, node: 1114, tag: h2, level: 9" node_number="1114">Conferences</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1115, tag: div, level: 8" node_number="1115"> <div class="valid" valid="valid" title="valid: True, node: 1116, tag: div, level: 9" node_number="1116"> Announce Your Conference </div> <div class="valid" valid="valid" title="valid: True, node: 1117, tag: div, level: 9" node_number="1117"> 16&#8211;18 February 2022 3rd MMCS: Shaping Medicinal Chemistry for the New Decade</div> <div class="valid" valid="valid" title="valid: True, node: 1118, tag: div, level: 9" node_number="1118"> 7&#8211;9 November 2022 7th International Symposium on Antimicrobial Peptides &#8211; AMP 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1119, tag: div, level: 9" node_number="1119"> More Conferences... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1120, tag: div, level: 7" node_number="1120"> <div class="valid" valid="valid" title="valid: True, node: 1121, tag: div, level: 8" node_number="1121"> <h2 class="valid" valid="valid" title="valid: True, node: 1122, tag: h2, level: 9" node_number="1122">Special Issues</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1123, tag: div, level: 8" node_number="1123"> <div class="valid" valid="valid" title="valid: True, node: 1124, tag: div, level: 9" node_number="1124"> Edit a Special Issue </div> <div class="valid" valid="valid" title="valid: True, node: 1125, tag: div, level: 9" node_number="1125"><div class="valid" valid="valid" title="valid: True, node: 1126, tag: div, level: 10" node_number="1126"> Special Issue in Antibiotics</div> Antimicrobial Susceptibility and Clinical Findings of Anaerobic Bacteria Guest Editor: Fernando CoboDeadline: 15 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1127, tag: div, level: 9" node_number="1127"><div class="valid" valid="valid" title="valid: True, node: 1128, tag: div, level: 10" node_number="1128"> Special Issue in Antibiotics</div> Spread of Multidrug-Resistant Microorganisms Guest Editors: Teresa Fasciana, Mara Di Giulio, Silvia Di Lodovico, Alberto AntonelliDeadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1129, tag: div, level: 9" node_number="1129"><div class="valid" valid="valid" title="valid: True, node: 1130, tag: div, level: 10" node_number="1130"> Special Issue in Antibiotics</div> Pharmacokinetic/Pharmacodynamic Models of Antibiotics Guest Editors: Andrew David Berti, Razieh KebriaeiDeadline: 5 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1131, tag: div, level: 9" node_number="1131"><div class="valid" valid="valid" title="valid: True, node: 1132, tag: div, level: 10" node_number="1132"> Special Issue in Antibiotics</div> Antibiotic Use in Clinical Infection: How to Reinvent Old Molecules and How to Squeeze Out New Ones Guest Editor: Stefano Di BellaDeadline: 31 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1133, tag: div, level: 9" node_number="1133"> More Special Issues </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1134, tag: div, level: 7" node_number="1134"> <div class="valid" valid="valid" title="valid: True, node: 1135, tag: div, level: 8" node_number="1135"> <h2 class="valid" valid="valid" title="valid: True, node: 1136, tag: h2, level: 9" node_number="1136">Topical Collections</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1137, tag: div, level: 8" node_number="1137"> <div class="valid" valid="valid" title="valid: True, node: 1138, tag: div, level: 9" node_number="1138"><div class="valid" valid="valid" title="valid: True, node: 1139, tag: div, level: 10" node_number="1139"> Topical Collection in Antibiotics</div> Discovery and MultiFunctionality of Anti-Microbial Peptides Collection Editors: Marc Maresca, Josette Perrier, Michael Lafond</div> <div class="valid" valid="valid" title="valid: True, node: 1140, tag: div, level: 9" node_number="1140"><div class="valid" valid="valid" title="valid: True, node: 1141, tag: div, level: 10" node_number="1141"> Topical Collection in Antibiotics</div> Antimicrobial Resistance and Anti-Biofilms Collection Editors: Ding-Qiang Chen, Yulong Tan, Ren-You Gan, Zhenbo Xu, Junyan Liu</div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1142, tag: div, level: 7" node_number="1142"> <div class="valid" valid="valid" title="valid: True, node: 1143, tag: div, level: 8" node_number="1143"> <h2 class="valid" valid="valid" title="valid: True, node: 1144, tag: h2, level: 9" node_number="1144">Jobs in Research</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1145, tag: div, level: 8" node_number="1145"> <div class="valid" valid="valid" title="valid: True, node: 1146, tag: div, level: 9" node_number="1146"> Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 1147, tag: div, level: 3" node_number="1147"> <div class="valid" valid="valid" title="valid: True, node: 1148, tag: div, level: 4" node_number="1148"> Antibiotics, EISSN 2079-6382, Published by MDPI <span class="valid" valid="valid" title="valid: True, node: 1149, tag: span, level: 5" node_number="1149"> Disclaimer <div class="valid" valid="valid" title="valid: True, node: 1150, tag: div, level: 6" node_number="1150"> The statements, opinions and data contained in the journal Antibiotics are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div class="valid" valid="valid" title="valid: True, node: 1151, tag: div, level: 5" node_number="1151"> RSS Content Alert </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1152, tag: div, level: 4" node_number="1152"> <div class="valid" valid="valid" title="valid: True, node: 1153, tag: div, level: 5" node_number="1153"> <h3 class="valid" valid="valid" title="valid: True, node: 1154, tag: h3, level: 6" node_number="1154"> Further Information </h3> Article Processing Charges Pay an Invoice <a class="valid" valid="valid" title="valid: True, node: 1155, tag: a, level: 6" node_number="1155"> Open Access Policy </a> <a class="valid" valid="valid" title="valid: True, node: 1156, tag: a, level: 6" node_number="1156"> Contact MDPI </a> <a class="valid" valid="valid" title="valid: True, node: 1157, tag: a, level: 6" node_number="1157"> Jobs at MDPI </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1158, tag: div, level: 5" node_number="1158"> <h3 class="valid" valid="valid" title="valid: True, node: 1159, tag: h3, level: 6" node_number="1159"> Guidelines </h3> <a class="valid" valid="valid" title="valid: True, node: 1160, tag: a, level: 6" node_number="1160"> For Authors </a> <a class="valid" valid="valid" title="valid: True, node: 1161, tag: a, level: 6" node_number="1161"> For Reviewers </a> <a class="valid" valid="valid" title="valid: True, node: 1162, tag: a, level: 6" node_number="1162"> For Editors </a> <a class="valid" valid="valid" title="valid: True, node: 1163, tag: a, level: 6" node_number="1163"> For Librarians </a> <a class="valid" valid="valid" title="valid: True, node: 1164, tag: a, level: 6" node_number="1164"> For Publishers </a> <a class="valid" valid="valid" title="valid: True, node: 1165, tag: a, level: 6" node_number="1165"> For Societies </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1166, tag: div, level: 5" node_number="1166"> <h3 class="valid" valid="valid" title="valid: True, node: 1167, tag: h3, level: 6" node_number="1167"> MDPI Initiatives </h3> <a class="valid" valid="valid" title="valid: True, node: 1168, tag: a, level: 6" node_number="1168"> Sciforum </a> <a class="valid" valid="valid" title="valid: True, node: 1169, tag: a, level: 6" node_number="1169"> MDPI Books </a> <a class="valid" valid="valid" title="valid: True, node: 1170, tag: a, level: 6" node_number="1170"> Preprints </a> <a class="valid" valid="valid" title="valid: True, node: 1171, tag: a, level: 6" node_number="1171"> Scilit </a> <a class="valid" valid="valid" title="valid: True, node: 1172, tag: a, level: 6" node_number="1172"> SciProfiles </a> <a class="valid" valid="valid" title="valid: True, node: 1173, tag: a, level: 6" node_number="1173"> Encyclopedia </a> <a class="valid" valid="valid" title="valid: True, node: 1174, tag: a, level: 6" node_number="1174"> JAMS </a> <a class="valid" valid="valid" title="valid: True, node: 1175, tag: a, level: 6" node_number="1175"> Proceedings Series </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1176, tag: div, level: 5" node_number="1176"> <h3 class="valid" valid="valid" title="valid: True, node: 1177, tag: h3, level: 6" node_number="1177"> Follow MDPI </h3> <a class="valid" valid="valid" title="valid: True, node: 1178, tag: a, level: 6" node_number="1178"> LinkedIn </a> <a class="valid" valid="valid" title="valid: True, node: 1179, tag: a, level: 6" node_number="1179"> Facebook </a> <a class="valid" valid="valid" title="valid: True, node: 1180, tag: a, level: 6" node_number="1180"> Twitter </a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1181, tag: div, level: 4" node_number="1181"> <div class="valid" valid="valid" title="valid: True, node: 1182, tag: div, level: 5" node_number="1182"> <div class="valid" valid="valid" title="valid: True, node: 1183, tag: div, level: 6" node_number="1183"> &#169; 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div class="valid" valid="valid" title="valid: True, node: 1184, tag: div, level: 6" node_number="1184"> <a class="valid" valid="valid" title="valid: True, node: 1185, tag: a, level: 7" node_number="1185"> Disclaimer </a> <div class="valid" valid="valid" title="valid: True, node: 1186, tag: div, level: 7" node_number="1186"> The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a class="valid" valid="valid" title="valid: True, node: 1187, tag: a, level: 7" node_number="1187"> Terms and Conditions </a> <a class="valid" valid="valid" title="valid: True, node: 1188, tag: a, level: 7" node_number="1188"> Privacy Policy </a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1189, tag: div, level: 3" node_number="1189"> <div class="valid" valid="valid" title="valid: True, node: 1190, tag: div, level: 4" node_number="1190"> We use cookies on our website to ensure you get the best experience. Read more about our cookies <a class="valid" valid="valid" title="valid: True, node: 1191, tag: a, level: 5" node_number="1191">here</a>. </div> <div class="valid" valid="valid" title="valid: True, node: 1192, tag: div, level: 4" node_number="1192"> <a class="valid" valid="valid" title="valid: True, node: 1193, tag: a, level: 5" node_number="1193">Accept</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1194, tag: div, level: 3" node_number="1194"> <div class="valid" valid="valid" title="valid: True, node: 1195, tag: div, level: 4" node_number="1195"> We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div class="valid" valid="valid" title="valid: True, node: 1196, tag: div, level: 4" node_number="1196"> <a class="valid" valid="valid" title="valid: True, node: 1197, tag: a, level: 5" node_number="1197">Never show this again</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1198, tag: div, level: 2" node_number="1198"> <div class="valid" valid="valid" title="valid: True, node: 1199, tag: div, level: 3" node_number="1199"> <div class="valid" valid="valid" title="valid: True, node: 1200, tag: div, level: 4" node_number="1200"> <h2 class="valid" valid="valid" title="valid: True, node: 1201, tag: h2, level: 5" node_number="1201">Share Link</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1202, tag: div, level: 4" node_number="1202"> <a class="valid" valid="valid" title="valid: True, node: 1203, tag: a, level: 5" node_number="1203">Copy</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1204, tag: a, level: 3" node_number="1204"> <i class="valid" valid="valid" title="valid: True, node: 1205, tag: i, level: 4" node_number="1205">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1206, tag: div, level: 2" node_number="1206"> <div class="valid" valid="valid" title="valid: True, node: 1207, tag: div, level: 3" node_number="1207"> <div class="valid" valid="valid" title="valid: True, node: 1208, tag: div, level: 4" node_number="1208"> <h2 class="valid" valid="valid" title="valid: True, node: 1209, tag: h2, level: 5" node_number="1209">Share</h2> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1210, tag: a, level: 3" node_number="1210"> <i class="valid" valid="valid" title="valid: True, node: 1211, tag: i, level: 4" node_number="1211">clear</i> </a> </div> <a class="valid" valid="valid" title="valid: True, node: 1212, tag: a, level: 2" node_number="1212">Back to TopTop</a> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>